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Synopsis 
As part of the organisation's strategy to improve its manufacturing logistics 
and supply chain management operations, they sponsored me on a Doctoral 
Program to research into the concept of customer service within the 
international Pharma-chemical and Pharmaceutical manufacturing industry. 
The research was structured in such a way that it formed part of my day to 
day manufacturing logistics assignments on and off site. 
The ideas cultured through the research have resulted in unprecedented 
improvements in both material an information flows on and off site. In 
particular, the systematic solicitation of our customer views through the 
Delphi technique has enabled the firm to gain a better understanding of its 
customer needs. Today, customer service performance as defined by our 
Pharmaceutical customers averages 98%. 
Nor is this all, for the continuous critiquing of various process steps through 
the virtuous circle of continuous improvement has enabled the organisation to 
improve the overall process lead times for two products by approximately 
35%. With these improvements, all customers (internal or external) get what 
they want on time, in full and at the right quality. 
By gaining a better understanding of our customer and supplier needs, 
through timely information flows, the manufacturing strategy for two products 
have moved from make-to-stock to make to order. To date, over £1/2m savings 
have been realised by virtue of the fact that no raw material or finished 
product inventory is held for these two finished products. 
At the back end of Pharmaceutical supply chains, the survey on sourcing 
patterns within the industry showed that Pharma-chemical manufacturing 
was still concentrated among the major Pharmaceutical organisations. In 
fact, the study showed that Pharmaceutical organisations with sales of less 
than £900m outsourced their bulk Pharmaceutical needs whereas those 
having sales in excess of the stated amount used a combination of internal 
and external sources to satisfy their bulk Pharmaceutical needs. 
At the front end of Pharmaceutical supply chains, the survey highlighted the 
fragmented nature of the industry with over 60% having sales of less than 
£500m. This fording supports the view held today that the industry is heavily 
fragmented with more consolidation likely. 
The improvements to date have in fact exceeded what was expected. The 
gaining of approval to manufacture another product can be partly attributed 
to the continuous improvement efforts and accomplishments. With senior 
management's support, each individual and teams on site are continuously 
questioning their processes and seeking ways to reduce or eliminate the 
associated non value adding activities. 
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Figure 1 txecutive summary's position on the Research Route map. 
About the Research Engineer: 
The Research Engineer works full time for the Pharma-chemical division of 
a major International Pharmaceutical company, headquartered in the 
United States of America. The research was sponsored by the company. 
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SECTION A 
Research Rationale, Methodologies and Scope 
Chapter 1. 
Industry Overview 
The Pharmaceutical industry is involved in the manufacture of human and 
animal health products primarily for their consumption. The industry 
developed in parallel to the progress and advances in taking care of the sick. 
Nowadays, so much importance is attached to the medicinal, chemical, 
biological and pharmacological research that before a drug makes it to the 
market, a organization would have invested a huge amount of capital. 
Pharmaceutical products are now Only made available to the public in 
conformity with state drug laws, either through one of the health 
professionals-a physician, dentists or veterinarian-and dispensed by a 
Pharmacist'. 
The recognition that effective manufacturing logistics and customer service 
policies are the key to an organization's long term profitability and ultimate 
survival has brought with it an understanding of their strategic importance 
in the Pharma-chemical sector, a vital link in the Pharmaceutical supply 
chain2. Around the developed world, the entire industry is going through 
unprecedented changes. Health care costs around the world are under 
pressure-even the formerly profligate United States of America is actively 
I With the exception of the over-the-counter preparations. 
2 See Figure 2 for a schematic diagram of a Pharma-chemical /Pharmaceutical supply chain. 
seeking ways to curtail their drug bill. As a result, the major players can no 
longer rely on finding instant markets for new products unless they offer 
demonstrable advantages over cheaper alternatives. Nor can they expect 
prices high enough to maintain the high margins enjoyed in the past. At 
the same time, the cost of discovering new drugs' is soaring at an alarming 
rate. 
The greatest pressure has come from the need to control spiraling drug bills. 
National governments and other agencies, which are the main customers of 
the Pharmaceutical industry, are looking for ways to stem the growth of 
health care costs. This puts enormous pressures on the manufacturing 
sector of the industry and has led to its complete metamorphosis. Although 
the industry is fighting back by pointing out that effective drugs which keep 
people out of hospital are highly cost effective, Pharmaceutical 
manufacturers are nonetheless facing more difficult times than before4. 
Since the early nineties, the sales of many Pharmaceutical firms have been 
depressed by a series of health care reforms that are either planned or about 
to be implemented in some of the world's biggest markets for curative 
products: United States, Frances Germany, Japan and United Kingdom6. 
3 Discovered drugs are usually given two names by the discovering company.: - An approved or a brand name. For 
example Panadol is the brand name for Paracetamol whilst Nurofen is the brand name for Ibuprofen. Discovered 
drugs are patented by the manufacturer so that other companies may not copy the product. After patent expiration, 
other drug companies may produce their own generic versions of the medicine. Generic medicines are simply 
different versions of the brand drug. They are usually less expensive and contain the same active ingredient. 
4 See Boateng(1996)2 pp. 3-60 for more details on the changes currently sweeping the industry. 
5 See Pharmaceutical Business News 12th July 1996 pp. 7. 
6See Financial Times March 1993& 27th September 1994. 
Germany, one of the world's biggest markets for pharmaceutical products 
has cut its drug spending since the beginning of 1993. Similarly the United 
Kingdom, Italy, France Sweden, Netherlands, Spain, and Belgium7 are all 
getting serious about stemming the growth in their drug bill. The dramatic 
changes in fortunes have all come about by the rising health care costs faced 
by all countries. Recent figures from the OECD indicate that spending on 
Pharmacy drugs has increased in all the industrialized countries with Italy 
showing the biggest jump8. In real terms, the UK's expenditure on health 
care has more than trebled over the same period'. Some reasons cited by 
leading researchers and publishersi0 for this rapid rise in cost include: - 
1) The pace of technological innovation, 
2) Demographic trends in most countries, 
3) Increased life expectancy, 
4) Changes in living conditions, 
5) Stress, 
6) Pollution, and 
7) Unemployment. 
Increasingly, the Pharmaceutical industry is realizing that in many of its 
markets, there is a trend towards a decline in the strength of the brand 
7 See Moore(1996). 
8 Ibid. 
9 Ibid. 
10 See for example Green(1994/6) and Moore(1996). 
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name and a consequent move towards cheap generic substitutes". Not 
suprisingly, the United Kingdom is not the only country urging medical 
practitioners to prescribe cheaper generic versions of the out of patent 
branded products'2. Quite simply, it is now becoming increasingly difficult 
to compete only on drug efficacy and corporate image. 
As the industry's main customers have cottoned on to this important saving 
potential, firms are finding it increasingly difficult to sustain market share 
and maintain sales once a product has lost its patent protection. A classic 
example is SmithKline Beecham's Tagamet when it lost its patent 
protection. With patent expiration in May 1995, sales in the United States, 
the largest market for medicinal products, fell 82% in three months". 
Similarly Glaxo-Wellcome' Zantac lost almost 50% of its sales in Germany 
when it lost its patent protection 14. 
To counteract such decline in fortunes, the industry is moving from a 
traditional strategy of corporate independence towards a collective 
strategy(vertical integration's, strategic alliances1, collaborative ventures" 
11 For example see Scrip Report No. 2044 21st July 1995 pp. 10 on Sandoz Pharmaceuticals and 
Pharmaceutical Business News Vol. 12 No 271 1996 on the French Government' move to encourage 
Generic Prescribing. 
12 Ibid. 
13 See Green 1995 and Hamilton (1995), Scrip Report 2056/57 pp. 10,13. 
14 See Price 1996. 
15Harrigan (1983) describes vertical Integration as a combination within a firm, functions that can 
be usually carried out by separate firms. 
16 See lubman and Langreth(1995). 
17 Scrip Report No. 2044 pp. 10 -11. 
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and value-added partnerships18) in which entities recognize their 
dependence on each other"'. In some cases, some firms like Glaxo, Merck, 
Bayer and American Home Products have entered into strategic alliances 
with leading over-the-counter and generic firms to directly market over-the- 
counter and generic versions of their out-of-patent products2°. Green(1995)a-a 
neatly sums up the reasons for the shake up and alliances under two main 
headings: - . 
I. Internal reasons 
II. External reasons 
Internal reasons 
Within the Pharmaceutical industry, many of the drugs which were 
developed in the sixties had produced rapid growth and were nearing the 
end of their patent protection period. This in effect meant loss of market 
share and most of the major Pharmaceutical firms were likely to be affected. 
They include Glaxo, Wellcome, Marion Dow, Syntex, SmithKline Beecham, 
Ciba Geigy, Merck & Co., Bristol Mayers and Squibb, Roche, and Pfizer2'. 
There is thus the need to find ways of protecting not only market share, but 
also profits. 
18Laming (1993) describes value added partnerships as being a form of relationship where trading 
partners work in concert for mutual benefit. 
19 See Financial Times 1994 & 1993. 
20 See Scrip Reports No. 2044,21st July 1995 pp. 23; Report No. 2058 pp. 7. 
21 Green(1995)a . 
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External Reasons 
The planned introduction of health care reforms particularly in the United 
States is bound to eat into the profit margins of the major Pharmaceutical 
firms. Nor is this all, for most industrialized countries are seriously seeking 
means to curtail their rising health care bills. To protect market share and 
profits, Pharmaceutical manufacturers are strategically protecting 
themselves through acquisition22. 
Such manoeuvres have enabled manufacturers to bypass such powerful 
buyers like Health Managed Organizations(HMO) to directly market their 
products to the consumer. It is therefore not surprising that between 1989 
and 1995, Lilly23, Merck & Company, SmithKline Beecham, to name but a 
few, decided to form strategic alliances with a number of companies to 
market and develop over-the-counter and generic versions of their out-of- 
patent pharmaceutical products. 
These developments have forced many managers and senior executives 
within the industry to recognize international customer service and 
manufacturing logistics systems within the Pharma- 
chemical/Pharmaceutical continuum as a weapon for competitive 
advantage. 
The decision to become more customer focused to 
1) Reduce response times to the market, 
22 Green(1995) op. cit. 
23 See Burton(1995). 
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2) Improve delivery reliability within its product supply chains, 
3) Reduce inventories in their product pipelines, 
4) Add value faster than cost, 
is clearly having an impact on how customer service is perceived. Both by 
early involvement in research and production process and by electronic data 
interchange, Pharma-chemical firms are increasingly being integrated with 
their Pharmaceutical customers. Some customer service re-engineering 
efforts in the industry have allowed some Pharma-chemical firms to: - 
1) Cut the lead time to their Pharmaceutical customers, 
2) Improve delivery reliability24 
3) Reduce inventories. 25 
4) Reduce complexities and, 
5) Be more flexible to respond to market changes whilst at the same time 
improving their operational efficiencies. 
Today, the need for optimum customer service performance as a means to 
streamline product supply chains has never been greater. Yet, the customer 
service function, in most cases, was a neglected component of many supply 
chain re-engineering efforts with its level of performance normally based on 
industry norms, management efforts, past practices and in some cases a 
total dis-regard for what the customer wanted in terms of performance. 
Today, customer values are being reshaped by national governments clearly 
24 To Pharmaceutical manufacturing and distribution centres. 
25 Bulk active inventories. 
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driven by the need to reduce costs. Emphasis is now on improving an 
individual life at a reasonable cost. Current developments in 
Pharmaceutical markets indicate that consumers will increasingly have 
more choice in what products they buy. This in effect means that medicinal 
products will move from being product focused to a more information and 
customer service driven products. 
For the various divisions of the organization especially Marketing, to 
compete successfully, the Manufacturing Division must have customer 
driven systems in place to pro-actively meet Marketing needs at a 
reasonable cost. Efficient and effective Customer service policies will 
immensely help the manufacturing division to support the Marketing 
organization outsmart the competition. 
The Top'15 Pharmaceuticals World Wide, 1993/1994 
Rank Previous Company Country Pharma sales % Change % Pharma 
Yrs. Rank on sales Total sales 
1 1 Merck &Co. US 8774.6 6.8 83.6 
2 2 Glaxo UK 8484 6 100 
3 3 BMS US 6524 3.3 57.2 
4 4 Hoechst Ger 6010.4 -0.5 21.6 
5 7 Roche Sw 5285.6 7.9 54.6 
6 6 SmithKline Beecham UK 5231.3 2.6 57.7 
7 11 Pfizer US 5128.5 12.5 68.6 
8 5 Ciba Sw 5103.5 -1.7 33.3 
9 8 Sandoz Sw 4972.2 1.8 48.7 
10 9 Bayer Ger 4792.2 2.6 19.3 
11 10 AHP US 4774.6 4 57.5 
12 12 Lilly US 4759 4.9 73.3 
13 13 Johnson& Johnson US 4490 3.5 31.8 
14 15 Abbott US 4389 9 52.2 
15 16 Takeda Japan 4204.9 15.5 64.2 
Table 1. Top 15 Pharmaceutical Companies in the World26. 
26 Source: - Scrip Yearbook 1995 pp. 77. 
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Table 1 presents a summary of the top 15 Pharmaceutical firms in the 
world. The two biggest drugs companies in the world controlled only 12% of 
the market in 1993 and 1994, with Merck having a lead of $290 million 
over Glaxo 27. Bristol Mayers and Squibb and Hoechst had sales in excess of 
$6 billion whilst Roche, SmithKline Beecham, Pfizer and Ciba Geigy 
recorded sales in excess of $5 billion each2ß. Sixty five percent of the world 
wide Pharmaceutical market is accounted for by the top fifty companies29. It 
is however expected that the merger mania that has swept the industry will 
close the gap between the major industry players in the coming years. 
Customer Service -A Definition 
Customer service is basically consistently satisfying a customer defined 
need by working closely with service" providers. These service providers 
can be external or internal to the organization. In addition, the end product 
could be tangible or intangible. To Perreault et. al, it was a package of 
measurable activities which provided utility to customers. To 
Blanding(1974), customer service was the chain of sales satisfying activities 
which usually started with the order entry and ended with the delivery of 
the product to the customer. This definition is limited in scope in that 
27 Scrip Yearbook 1995 pp. 77-79, Scrip, Jan 16th 1996. Since Jan 1995 Glaxo' acquisition of the 
Wellcome Foundation has pushed it to the top of the Pharmaceutical league table. See also 
Cope(1995) and Cookson(1995) reports on the Pharmaceutical industry. In 1996 Merck was joint 
number one with Glaxo-Wellcome with Novartis in third position. In terms of Market 
Capitalization Merck is still the biggest Pharmaceutical company in the world. 
28 Scrip Yearbook 1995 pp. 77-79. 
29 Scrip Yearbook 1995 op. cit. 
30 For example freight forwarders. 
customer service in today's business environment has been proved to 
transcend just the sales satisfying activities suggested by Blanding. 
Lalonde and Zinser's(1976) described customer service as 
"Those activities that occur at the interface between the customer and the co- 
operation which enhances or facilitate the sale and use of the corporation's 
product or services. " 
In their study, they concluded that customer service was defined mostly in 
one of three ways: 
1) As an activity that has to be managed e. g. invoicing and handling of 
customer complaints. 
2) As a performance measure such as the ability to ship 95% of orders 
received complete within forty eight hours. 
3) As an element in the total corporate philosophy rather than as an activity 
or a set of performance measures. " 
To Tucker(1980&3), customer service was 
"Generally presumed to be a means by which companies attempted to 
differentiate their product, keep customers loyal, increase sales and improve 
profits': 
Lalonde, Copper and Noordeweir(1988) described customer service as a 
process which took place between three parties- a buyer, a seller and a third 
party. During the process value was added to the product or service 
31 See Lalonde and Zinser 1976 pp. 156-159. 
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exchanged. The value added during the transaction could be short term as 
a single transaction or longer term in a contractual relationship. The value 
added was also shared. Lancioni and Myroslaw(1989) affirmed that 
customer service included all those activities over and above the assembly 
and sale of merchandise that was necessary to attract and retain customers. 
In addition, it included such activities as prompt response to customer 
inquires, complaints or providing information about shipment. 
To Kji(1989), customer service 
"Encompassed all the activities used by a firm to win and retain 
customers........ In addition, they were characterized by inseparability 
intangibility and inability to be stored....... " 
Kyi also emphasized the fact that customer service was not an inventoried 
item that could be called upon to rectify a situation. Getting it right the first 
time was therefore a necessity. 
. 
Lambert with Sharma(1990) and Stock(1993) viewed customer service as all 
the activities which put together as a package constituted what a customer 
would receive for a purchase. 
To Livingstone(1992), customer service was more than just providing a 
product to a customer. Like some earlier researchers, she was also of the 
view that customer service was the ability to satisfy a customer need in a 
manner which guaranteed a repeat purchase. All these authors were able 
to show that an improved service can lead to: - 
11 
1) An increased repeat business from existing customers. 
2) Increase profits, 
3) Improved morale, 
4) Development of a service culture, 
5) Improved productivity and communication. 
Wagner and La Garce(1981) also made the following assertions: - 
1) The need for firms to redevelop and tailor customer service to their 
customer needs if competitive advantage was to be gained. 
2) Service offered to customers must be continuously reviewed as an 
integral part a firm's strategy. 
The definitions given so far are consistent with each other in that they view 
customer service as being provided by a supplier to a customer. Again, it 
requires that a customer service activity be managed to ensure that utilities 
are provided in a way required by the customer. With customer service 
being a non-price competitive strategy, there is the need to reshape the 
customer service mix as the ability to use price as a mechanism for 
maintaining market dominance is weakening. Although numerous studies 
and publications have been done in this area, there seems little consensus 
about the number and range of activities and attributes that make up 
international customer service32. 
32 Boateng(1996)2 pp. 64-123. 
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Customer Service and Pharma-chemical manufacturing 
As already mentioned, a lot of sweeping changes coupled with generic 
substitution of branded products and the growth in over-the-counter sales 
have begun to significantly affect sales and profit margins enjoyed by the 
major players in the Pharmaceutical industry. Up until now, all that the 
Pharmaceutical and Pharma-chemical manufacturer needed to do was to 
keep churning out innovative products and use a huge sales force to ensure 
that their products were prescribed by Physicians33. Current indications 
lead one to conclude that the industry's biggest customers, governments and 
health care buyers, 34 will drive the pace of change in the industry, resulting 
in a more dynamic and hostile environment than ever before. The changes 
currently sweeping the industry have forced all the leading Pharmaceutical 
manufacturers to adopt new strategies to compete and survive into the 
millennium. 
The strategies adopted include the following: - 
1) Organic growth through mergers and acquisitions, 
2) Be more customer focused. 
3) Scaling back through divestation to concentrate on core competencies 
and 
4) Redefinition of roles in the industry by acquiring PBMs35'. 
33 Thanks to Mr Pike and Dr. Mendez for this assertion. 
34 The National Health Service (NHS) in the UK and Health Maintenance Organizations(HMO) in the USA. 
35 Pharmacy Benefit Management. These organizations basically buy medicinal products in bulk from the major 
Pharmaceutical companies on their customer behalf. 
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Government actions in terms of encouraging Generic substitution and OTC36 
buying of pharmaceutical products indicate consumers will have to take 
more responsibility for their health. To this end, perceived values will take 
on a new meaning in the industry. 
For the Pharmaceutical manufacturer to be responsive to its front end 
customer needs, its bulk supplier37 will in turn have to reconfigure its 
processes and systems to have a more customer focused operation. 
From the Delphi exercise , it became clear that not only is the setting of a 
customer service policy an arduous task but also measuring the desired 
customer service attributes was practically impossible. Nor is this all, for 
the meaning of the term customer service and the significance attached to 
each of the variables were still highly situational. 
Nowadays, there is no longer a concern over whether a service need will be 
satisfied but rather, what level of service is deemed most appropriate to 
help an organization sustain its competitive advantage. A bad service may 
be rectified after a complaint but the damage done might be irreparable. In 
a nutshell, customer service as a competitive tool can significantly affect an 
organization's standing in today's highly competitive Pharmaceutical 
industry. 
36 Over the counter. 
37 That is the Pharma-chemical manufacturer. 
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Chapter 2. 
The Scope of the Research 
Figure 2 illustrates the complexity of the manufacturing channel structure 
for a pharmaceutical product. The Pharma-chemical manufacturer produces 
and distributes the bulk active pharmaceutical product to either; - 
1) A Generic Pharmaceutical manufacturer, 
2) Ethical Pharmaceutical manufacturer or 
3) Over-the Counter Pharmaceutical manufacturer or, 
4) To all three types of manufacturers. 
Upon receipt of the bulk active, the Pharmaceutical manufacturer converts 
the bulk active into dosage form's. The Pharmaceutical manufacturer then 
sells the products: - 
1) Through its distribution channels39 to the consumers e. g. Over-the- 
counter preparations or 
2) Gets the product to the consumer through a prescription given by a 
qualified doctor e. g. prescription and generic drugs. 
In most cases the Pharma-chemical manufacturer is a vertically integrated 
division of the Pharmaceutical organization40. This research was restricted 
38 For example Capsules, tablets, liquid etc. 
39 Pharmacists. 
40 Size in terms of sales and ethical volumes play a key role in determining whether a pharmaceutical manufacturer 
makes or buys its bulk active pharmaceutical needs. 
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to the Pharma-chemical and Pharmaceutical continuum" and excluded the 
consumer interface. 
For the purposes of this research, customer service was viewed as the 
services or activities required by operational managers42 at Pharmaceutical 
manufacturing sites in addition to the "bulk actives"" supplied by Pharma- 
chemical entities. 
A Delphi exercise on International customer service was designed to elicit 
the customer service needs of the Pharmaceutical manufacturer and as a 
benchmark for appraising the impact of any changes on the local policy on 
International Customer service. The exercise was constructed in such a 
way that the customer service attributes perceived by Pharmaceutical 
customers to be significant could be systematically solicited and collated 
through the Delphi Technique44 and used for configuring an International 
Customer Services Policy. 
41Drug production is in two stages: the preparation of the physiologically active ingredients, and its conversion into 
dosage form. Throughout this study, the first stage will be referred to as Pharma-chemical or Bulk 
Pharmaceutical or primary production. The products made at the primary stage will be referred to as bulk actives. 
The latter will be referred to as Pharmaceutical or secondary production. The products made at the secondary 
stage will be referred to as formulated Ethical or prescription drugs. Ethical prescription drugs are pharmaceutical 
products that can only be obtained through a prescription from a medical doctor. over-the-counter drugs are 
products that can be obtained in any store or pharmacy. 
420perational managers are those people in middle to top management positions in Purchasing, Materials 
management, Logistics and Customer service positions within the Pharmaceutical industry. Unless otherwise 
stated, the "customer" throughout this research is the Pharmaceutical manufacturer within the Pharma-chemical- 
Pharmaceutical distribution channel. 
43 Unlike other industries the quality of a pharmaceutical product is unquestionable. 
44 The Delphi Technique is basically a technique for systematically soliciting a consensus of opinion on an issue 
from a panel of experts. 
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Figure 2-Pharma-chemical-Pharmaceutical supply chain 
Overall Objectives of the Study. 
The overall objectives of the study were to: - 
1) Determine the sourcing strategies of the major Pharmaceutical 
manufactures. 
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2) Understand some of the factors that influenced the sourcing strategies of 
the major Pharmaceutical manufacturers. 
3) Elicit a consensus of opinion on International Customer Service 
attributes and from it derive a generic policy that can be adopted by all 
Pharma-chemical manufacturing sites within the organization. 
4) Determine the relevant attributes of international customer service from 
the perspective of the Pharmaceutical manufacturing entities and 
Strategic planning. 
5) Ascertain the perceived significance of each customer service attribute 
from the Pharmaceutical manufacture's perspective. 
6) Investigate how process mapping could be engaged to evaluate the 
various core processes associated with the customer service function and 
some products. 
Research questions 
Sourcing Patterns of the Major Pharmaceutical Manufactures. 
1) What are the bulk sourcing strategies of the major pharmaceutical 
manufacturers.? 
2) What determines whether the bulk active is sourced externally or 
internally? 
3) What are the key criteria for successfully applying the survey method? 
Customer Service 
1) What are the customer service requirements of Pharmaceutical 
manufacturers?. 
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2) What customer service attributes are commonly perceived by the 
Pharmaceutical manufacturer to be: - 
w Extremely important? 
.- Important? 
'"- Least Important ? 
i Not Important? 
3) What customer service benchmarks needs to be implemented ? 
4) How do Pharmaceutical manufacturers rate the customer service 
performance of their Pharma-chemical suppliers relative to best practices 
against the following: - 
'"- Excellent? 
. "- Good ? 
m. Below Average? 
w Poor? 
5) For a step change in performance, what customer service metrics need to 
be implemented by Pharma-chemical sites? 
6) What are the key criteria for successfully applying the Delphi Technique? 
Process Mapping 
1) What value will process mapping bring to the organization? 
2) What steps are needed to conduct a full scale process mapping exercise? 
3) What issues need to be addressed for a successful process mapping 
exercise ? 
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4) What are the key criteria for applying the process mapping concept? 
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SECTION B 
Methodologies Engaged and Findings 
Introduction. " 
The following methodologies were engaged for the various parts of the 
research. 
1) To determine sourcing Pharmaceutical manufacturers the survey method 
was adopted for this purpose. 
2) For eliciting the customer service variables, the Delphi technique was 
engaged. 
3) Process mapping was adapted to systematically critique the sequence of 
steps associated with various customer service processes. 
Data Collection. 
Electronic mail and internet were used to collect the data from the panel of 
experts. For both the Delphi and survey, a personalized letter of 
introduction, why the study was important and an offer to provide the 
respondent with a summary was either posted or electronically sent to each 
participant. 
Data Analysis 
Utilized descriptive analysis which included measures of central tendencies 
and dispersion to describe the distribution of the responses in all sections of 
the research. A brief description of descriptive analysis is given below. 
45 For more details on the various research methodologies please refer to Boateng(1996)2 pp. 30-46, and 
Boateng(1997)1 pp. 1-40. 
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Descriptive analysis 
This basically refers to the transformation of data from a population sample 
to make it more meaningful to all interested parties or individuals. In most 
research, making collected data meaningful through frequencies and 
percentage distributions might be good enough for the interested party to 
make their own judgments. Beyond this, one can go into more sophisticated 
analysis like hypothesis testing and associations between the various 
variables. Under descriptive statistics are frequencies, percentages, mode, 
median, tabulation, and cross tabulation. 
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Chapter 3. 
The Survey Method and the Pharmaceutical industry. 
Tull and Albaum(1973) described survey research as a means to get 
information from a sample of people by the use of questionnaires. 
Hart(1987) cited four main reasons for the popularity of the survey 
research: - 
1) Survey research provides the researcher with the means to gather both 
quantitative and qualitative data. 
2) Lots of information can be collected from survey research. 
Kerlinger's(1973) earlier book on behavioral science also made mention of 
this fact. 
3) Postal surveys tend to be a less expensive option to telephone interviews. 
4) Through survey research, a large audience can be reached. 
Babie(1973) rightly pointed out that as a tool, the survey method was 
logical, deterministic, general, parsimonious and specific. 
The survey method was engaged for the following reasons: - 
1) Comprehensive- Appropriate to most types of research. 
2) Customized-Easily customized to suite need. 
3) Versatile-Very robust as a tool. 
4) Flexible-Can be easily changed in the light of new information. 
5) Efficient-Where there is a limited budget, it can be used to reach a wide 
population sample. 
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To ascertain Clingiroglu's(1975) assertion that size generally played a major 
role as to whether a Pharmaceutical manufacturer in-sourced or out-sourced 
its bulk actives, a survey was carried out to determine the sourcing 
strategies of the major Pharmaceutical manufacturers operating in and 
outside United Kingdom. The design was based on a very simple likert 
scale. Respondents were asked to give their estimates by ticking the 
appropriate box(es). The questionnaire was basically structured under four 
major questions: - 
Questions 1&2 were used to: 
r. - Identify the manufacturer, 
i. - Type of products manufactured, and 
w Percentage split among products if involved in the manufacture if 
different pharmaceuticals. 
Questions 3&4 were used to establish the following: 
w Whether or not the Pharmaceutical manufacturer had vertically 
integrated plants that manufactured the bulk active for the 
formulations"sites or 
w- Out-sourced the bulk actives. 
ow A combination of both internal and external sourcing. 
w Percentage sourced from internal and external bulk 
manufacturers. 
46 Throughout this report formulation and Pharmaceutical sites will be used interchangeably. For the purpose of this 
research the two terms should be treated as being the same. 
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w Whether there is some form of strategic alliance if bulk actives 
were sourced externally' and . 
w Estimated sales of each organization. 
A total of one hundred sixty questionnaires were posted to 
1) All the registered members of the Association of British Pharmaceutical 
manufacturers. Well over 90% of the top fifty biggest48 Pharmaceutical 
companies in the world are registered members of this organization. 
2) Customers and affiliates of the sponsoring organization located locally 
and internationally. 
A response rate of fifty six percent was achieved. The internal response rate 
was over ninety eight percent. Participants in the survey included 
Managers, Directors and a Chief operating officer of a major organization. 
Over 65% of these individuals were in material logistics and corporate 
planning positions. 
47 For the purposes of this research strategic alliance and joint venture agreement are considered to be the same. 
48 In terms of world wide product sales. 
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Findings'-9 
THE PHARMA-CHEMICAL AND PHARMACEUTICAL INDUSTRY 
Table 2 presents the distribution of sales among the respondents. Over 50% 
had sales below £300 million with approximately 11% having sales in excess 
of £4000 million. The distribution of the results provided further evidence to 
support the view that the industry was heavily fragmented. 
Value 
xs£50m 
Value Label 
1 
Frequency 
10 
Percent 
11% 
Valid Percent 
11% 
Cum Percentage 
11% 
£51-200m 2 20 22% 22% 33% 
£201-350m 3 18 19.8% 19.8% 52.7% 
£351-500m 4 7 7.7% 7.7% 60.4% 
£501-650m 5 4 4.4% 4.4% 64.8% 
£951-1100m 8 3 3.3% 3.3% 68.1% 
£1100-2100 9 5 5.5% 5.5% 73.6% 
£2101-3100m 10 9 9.9% 9.9% 83.5% 
3101-4000 11 4 4.4% 4.4% 87.9% 
£4001-5000m 12 4 4.4% 4.4% 92.3% 
x; ->£5001m 13 7 7.7% 7.7% 100% 
Total 91 100% 100% 
Table 2- International Pharmaceutic al Industry Break down by sales 1994. 
Some industry experts including Green et. al and Nolf and Wimer(1997) 
point out that the shake up of the industry is likely to continue into the next 
millennium. 
49 Please refer to Boateng(1996)2 pp. 30-46 and appendix Al for more details on statistical findings from the survey 
on the Pharmaceutical industry. 
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Table 3 provides a summary of the distribution of the responses in 
relation how bulk actives were sourced. Participants were asked to 
state whether their bulk active requirements were: - 
a) Internally sourced, 
b) Externally sourced or 
c) Internally and externally sourced. 
Value Expected Count YES NO ". Total 
x5£50m 1 0 10 10 
11% 
£51-200m 2 0 20 20 
22% 
£201-350m 3 0 18 18 
19.8% 
£351-500m 4 0 7 7 
7.7% 
£501-650m 5 0 4 4 
4.4% 
£951-1100m 8 2 1 3 
3.3% 
£1100-2100 9 5 0 5 
5.5% 
£21013100m 10 8 1 9 
9.9% 
3101-4000 11 4 0 4 
4.4% 
£4001-5000m 12 3 1 4 
4.4% 
x; ->£5001m 13 7 0 7 
7.7% 
Total 29 62 91 
31.9% 68.1% 100% 
Table 3-Cros s tabulation of b ulk sourcing patterns by sales. 
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As can be seen from the responses, size in terms of sales, is one of the 
factors that determine whether a Pharmaceutical manufacturer sourced its 
bulk actives from internal or external Pharma-chemical manufacturers. 
Over 60% of the Pharmaceutical manufacturers with sales of less than 
£900m indicated that they did not source their bulk actives from internal 
sources whereas over 25% of Pharmaceutical manufacturers with sales in 
excess of £900m used both internal and external entities to satisfy their 
bulk active needs. The findings support Cilingiroglu's(1975) assertion that 
the bigger a Pharmaceutical company, the likelihood of the organization 
having an internal Pharma-chemical manufacturing entity to satisfy its 
bulk actives. It also reaffirmed the view held today by many professionals 
that size in terms of sales played a major role as to whether Pharmaceutical 
manufacturer made or bought its bulk actives. 
Key criteria for the successful application of the survey method 
Experience has shown that in order to successfully apply the survey method 
to gain a better understanding of a subject or a problem, a number of issues 
need to carefully considered. The include the following: - 
1. Always use simple unambiguous questions to: - 
ow Reduce the risk of partially completed questionnaire. 
__ Mis-interpretation of questions. 
w Mis-understanding vis-a-vis the objective of the study. 
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2. Whenever possible, the questionnaire should be addressed to a 
particular person within an organization. 
3. Questionnaires to non-English speaking countries should be in the 
local language. 
4. To improve the response rate, a reminder must be sent to non 
respondents, as soon as possible. 
5. Use phrases and words that can be easily understood by the 
respondents. 
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Chapter 4. 
The Delphi Technique and International Customer Service". 
The Delphi Technique is a method for systematically educing experts' 
opinions, knowledge and judgments on a complex problem52. The Delphi 
method was utilized to elicit the international customer service needs of the 
Pharmaceutical manufacturer because of the advantages it enjoys when 
attempting to arrive at a set of action plans particularly in relation to 
controversial and subjective issues". Besides, it allows one to generalize to 
a wider population with a high degree of confidence54. In addition, the latter 
stages which involve a highly structured questionnaire to gather data in a 
form that is quantitatively analyzable is easily replicable and reliable. As a 
method, for consulting expert opinion, the Delphi Technique has over the 
years gained acceptance. 
Originally, it was primarily developed and used for long range forecasting in 
technological organizations. Although still used widely for such purposes, 
its application has spread to the following: - 
a) Educational policy research". 
50 For more details on the Delphi technique, and Customer service please refer to Boateng(1996)1 pp. 25-46 
Boateng(1996)2 pp. 64-123 and Boateng(1997)1 pp. 13-27,41-106 respectively. 
51 An Expert in this context is an individual in a relevant position and with the relevant background or professional 
experience to positively contribute to the problem resolution. 
52 Moore(1987) pp. 50-1. 
53 Boateng(1996)1 pp. 25-38. 
54 Udinsky, Osterlind and Lynch(1981) Dajani Sincoff and Talley(1979) Samuel (1986). 
55 Linstone and Turoff(1975). 
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b) Entrepreneurship56. 
c) Chemical industry57. 
d) Health care planning58. 
e) Productivity Improvement".. 
f) Gathering information for Information system design60. 
g) Social policy Implementation". 
Its widespread use has resulted in many variations. Nonetheless, the 
technique has not lost many of its original formats. Moore(1987) 
categorized the application of the Delphi Technique under six main 
groupings: - 
a) Identification of goals and objectives. 
b) Arraying possible alternatives. 
c) Establishing priorities. 
d) Revealing group values. 
e) Gathering information and 
0 Educating a respondent group. 
Dijk(1989) also professed that the Delphi technique could be used in 
generating an understanding on an issue. 
56 Gartner(1990). 
57 Estes and Kuesport(1976). 
58 Schoeman and Majahan(1977). 
59 Sahu and Pradip(1989). 
60 Perez and Schuler(1982). 
61 Buck, Gross, Hakim and Weiblatt(1993). 
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As can be seen from the list, the Delphi technique is suited to a whole host 
of inquires. It is suited to problems that involve a mixture of scientific 
evidence and statistical information. As a research tool, it offers the 
flexibility, scientific rigor, validity, and purposiveness, which can sometimes 
be difficult to attain with other research methods. As Linstone(1975) 
pointed out, if a problem did not lend itself to precise analytical techniques, 
it could benefit from Delphi. With advancements in technology, it is 
expected that the use of Delphi will expand even further as researchers 
learn about the benefits of its use. 
Characteristics of the Delphi Technique 
As explained in volumes 2&462, the Delphi Technique has the following 
characteristics: -Anonymity, multiple iteration, feedback and convergence of 
distribution answers and a statistical group response. This is what makes 
this process unique among other research tools. 
Delphi Accuracy and Reliability 
Delphi accuracy has been successfully put to rigorous testing by various 
authors including Wouldenberg(1991), Campbell(1966) and Riggs(1983). As 
Martino et. al pointed out, questioning Delphi accuracy was not the prime 
issue. Rather, a researcher must seek to find out whether it captures the 
view of the carefully assembled panel of experts. Despite the fact that over 
the years the Delphi technique has been used in a variety of situations 
62 Boateng(199617)1 
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resulting in a number versions, it has retained its basic form as popularized 
by Dalky and Helmers(1963). 
Delphi and Customer Service. 
In previous volumes63, the principles underlying the customer service 
concept as postulated by various authors including Lalonde and 
Zinser(1976) Lambert and Stock(1993) Roscitt(1990), Levy(1981), and 
Gearson(1993) were critiqued. From the review of the literature and 
various publications, it became obvious a lot had been written on the 
concept with various authors providing steps to achieve world class 
customer service performance. Lambert and Stock(1993) for example, 
provided a four step process for achieving the desired level of customer 
service. This involved an external audit, an internal audit, identification of 
solutions and establishment of levels. Shycon(1989) similarly recommended 
an external audit to understand the needs of the customer. Copper, Lalonde 
r- 
and Noordeweir's(1988) normative model developed in association with the 
Council of Logistics Management employs fewer customer service elements 
but unfortunately requires substantial statistical input, time and effort 
which makes it unsuitable for immediate policy analysis and decisions. 
Roscitt(1990) and Stern and Sturdivant(1987) also provided invaluable 
insights into customer service management. Unfortunately, they did not 
provide a formal way for analyzing and implementing their postulations. 
63 Boateng(1996)1 pp. 5-11 and Boateng(1996)2 pp. 64-123. 
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Lambert and Stock's model for improving customer service although 
comparatively more simplistic also requires significant statistical analysis, 
time and effort and significant amount of data input. The level of 
sophistication across industries tends to vary and any model on improving 
customer service must take this into account. Increasingly, Logisticians are 
realizing that many facets or dimensions of customer service such as 
information exchange, delivery reliability and, after sales service are 
addressed in so many different ways. To this end, there is the need to seek 
the views of the customer any time a customer service policy is being 
evaluated. 
Reasons for Engaging the Delphi Technique. 
In volumes 2,3&4, the advantages of engaging the Delphi technique to 
arrive at a set of action plans particularly in relation to controversial and 
subjective issues were well documented". The Delphi technique was 
engaged because of the following: - 
1) Virtual elimination of bias of an individual in assessing the 
importance of any of the customer service attributes. The elimination 
of this bias helped develop a common Customer Service Logistics 
theme. 
2) As already mentioned, customer service is defined in so many ways. 
The utilization of the Delphi Technique helped alleviate some of the 
64 For more details see Boateng(1996)I&2 and Boateng(1997)1. 
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prevailing confusions regarding the distinctions(if any) between local 
and international customer service. 
3) Though various attempts have been made by various academics and 
consultants to measure and define customer service on a number of 
variables, many of the measures are largely dependent on 
organizational preference. Thus any measure an organization chooses 
does not necessarily ensure that the needs of their customers are 
satisfied. The application of the Delphi technique to directly seek the 
views of the Pharmaceutical customer was thus deemed appropriate. 
4) Currently, there is an absence of a simple but detailed methodology 
for eliciting a consensus on international customer service attributes. 
5) The application of the Delphi technique was more likely to provide 
sufficient information on policy issues relating to customer service. 
6) Although there have been numerous studies on the importance of 
optimum customer service performance, the priority to be attached to 
any of the attributes in an organization is still highly dependent on 
what value an organization or individual attaches to its importance. 
7) As international logistics customer service cuts across various 
organizational and national boundaries , (and no Policy currently 
exists within the organization), measuring the Pharma-chemical 
customer service performances are currently very difficult if not 
impossible. This is primarily due to the fact that organizations have 
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different measures as to how good or bad the quality of the customer 
service is. 
Though the Delphi technique has been primarily used in technological 
forecasting, Pradip and Sahu(1989) successfully applied it in developing 
productivity measures. Its scope thus lies in applying the technique to 
other aspects and problems such as eliciting a consensus on International 
Customer Service. 
The Delphi Team. 
The team was made up of people in some of the following positions. 
1) Director of World wide Pharma-chemical Planning. 
2) Supply Chain Managers for products with world wide sales of between 
$10 and $1000 million. 
3) Director of Logistics(NAFTA Region). 
4) Director of World wide Product Supply Planning. 
5) Director of Operations South America 
6) Director of Operations China. 
7) Director of Operations Japan. 
8) Director of Product Supply Europe. 
9) Director of Planning Europe. 
10)Materials Managers, " 
11)Logistics Managers" 
65 Were randomly picked from various locations around the world. 
66 Ditto. 
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12)Director of Logistics Planning and Support. 
I3)Pharmaceutical/Pharma-chemical plant Mangers. 
Why these People on the Panel. 
These people were selected on the following grounds: - 
a) They had the broadest knowledge about their customer service 
requirements and 
b) Were familiar with the current performance level being achieved by their 
Pharma-chemical suppliers. 
In addition, not only did they know what direction they wanted customer 
service to take, but were also most likely to offer breakthrough ideas to help 
Pharma-chemical manufacturing sites become more responsive to their 
customer needs. 
Location of Participating Organizations. 
Included in this study were both independent firms67 and vertically 
integrated divisions of the multi-national" sponsoring organization, both 
domestic and foreign, operating in and outside the United Kingdom. 
Locations of the Pharmaceutical manufacturing sites included 
South Africa, Morocco, Lebanon, Turkey, United States(3 sites), Canada, 
Brazil, Mexico, Puerto Rico, Venezuela, Costa Rica, Australia, China Korea 
Taiwan, Japan, Holland, United Kingdom, France, Germany, Ecuador, 
Portugal, New Zealand, Sweden and Argentina. Pharma-chemical site 
67 Independent firms with some business connection with the sponsoring organization. 
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locations included Ireland, United Kingdom, United States(3 sites), and 
Puerto Rico. 
68Hood and Young (1979) define a multi-national enterprise as a corporation which owns (in whole or in part), 
controls and manages income generating assets in more than one country. 
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The Delphi Process 
Figure 3 presents a schematic diagram of the Delphi process. Following is a 
brief description of each stage. 
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rigure s- i ne wages or ueipni exercise. 
Stage 1 
Selection of the Panel of Experts. 
This stage involved the selection of specialists whose judgments on 
International Customer Service attributes were elicited. In all, fifty five 
panelists located in over twenty countries were chosen. 
In carrying out the survey exercise in section B69 a number of relevant 
contacts whose background and experience were to later prove invaluable to 
the exercise were made. After contacting the ones in middle to senior level 
management ten agreed to take part in the study with the understanding 
that: 
a) They will remain anonymous with confidentiality guaranteed. 
b) All the results will be made known to them. 
c) They will participate in some future studies originating from their 
respective organizations. 
69 Boateng(1996)1 pp. 30-46. 
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The fifty five people were made of the following: 
Relationship 
External Experts 
Number 
10 
Position 
Senior executive and Directors 
Percentage 
18% 
Internal Experts 22 Senior executive and Directors 40% 
Experts from Strategic alliance /partners 15 Senior managers and managers 27.27% 
Other 8 From Finance; Marketing; Research, Vice 
Presidents and other ..... 
14.54% 
Total 55 100% 
Table 4-The Make-up of the Panelists 
Well over fifty percent of the external experts were located in Europe. As 
per the internal experts and those coming from entities with which the 
sponsoring organization had strategic alliances, they were chosen in 
consultation with our major customers and senior personnel within the 
organization. Over ninety percent of the internal experts were also located 
outside Europe. Their backgrounds and professional experience to date 
played a key role in their selection. 
Sta ec, e22 
Formulation of the Delphi Questions and Distribution to Panelists 
This step included asking broad open ended questions about international 
customer service attributes. At this stage, one was seeking to elicit some 
broad definitions of customer service from the respondents. The 
questionnaire was generally unstructured and open ended. The intention 
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was not to limit in any way, the range of answers from the experts. Open 
ended and broad questions offered the respondent maximum freedom to 
interpret the question. A response rate of 100% was achieved for this 
round. 
Stage 3 
Distribution of 2nd questions 
Stage 3 entailed asking panel members to rank preliminary priorities 
among responses generated in stage 2. A response rate of 90% was achieved 
for this stage. 
Stage 4 
Distribution of 3rd questions 
Panel members were asked to vote again on the items which were outside 
the normal distribution. A response rate of 90% was once again achieved 
for stage 4. 
Definition of Value Labels 
Against each label constructed on a likert type scale, panel members were 
asked to express a view on each statement against the following: - 
Extremely important 
These are attributes that significantly and positively impact customer 
service performance. An attribute that scores the most votes70 against this 
7 The Mode. 
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label should be fully addressed and implemented within the next three 
months. 
Important 
These attributes affect customer service performance but benefits may not 
be realized immediately. Nonetheless, it should be implemented within the 
next twelve months as it will significantly contribute to the organization's 
continuous improvement initiative. 
Least Important 
These attributes will not impact customer service performance within the 
next twelve months. However, for continuous improvement purposes it is 
worth considering for long term initiatives. 
Not important 
With these attributes, the panelist did not foresee any quantifiable benefits 
to the organization. 
None of the Options 
Panelist was not in a position to make a judgment on the issue. 
For the benchmarking purposes, the experts were asked to vote on the 
following: - 
Excellent 
Attribute that received an excellent rating by the panelist meant that 
performance was in line with world class practices. There was however the 
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need to continuously monitor the competition if world class performance is 
to be sustained. 
Good 
There was consistent performance with these attributes. However, when 
compared to world class practices, customer service performance was 
unsatisfactory. As such, significant improvements were needed to align 
processes to world class practices. It would be extremely useful to consider 
process mapping and benchmarking. 
Below Average 
There was inconsistent performance which was causing operational 
problems. Urgent attention was thus needed to improve performance. 
Poor 
Attribute needed immediate attention as poor performance was constantly 
causing operation problems and uncertainties. 
Martino(1975) like Wouldenberg(1991) reported the reliability of the Delphi 
technique. He indicated that findings obtained through a Delphi study 
closely matched overall group perception. A number of leading researchers 
including Linstone and Turoff(1975) and Samuel(1986) drew similar 
conclusions except that they concluded that the size of the panel influenced 
the reliability of the findings. For each statement in rounds two and three 
the following was calculated using SPSS: - 
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a) The mean. 
b) Mode. 
c) Median. 
d) Percentage and 
e) Frequency. 7' 
Sta ece55 
Distribution of summary to Panel 
The distribution of responses from stage 4 was accepted as the group's 
position. This represented the nearest thing to a consensus on 
International customer service attributes. It affirmed the spread of 
opinions and consensus answers and minority arguments in defense of 
deviant responses on customer service. 
Findings' 
As already mentioned, fifty five panel members drawn from various 
professional backgrounds and located at various places around the globe 
were chosen at random to participate in the study. 
The first questionnaire was open ended and panelists were asked to state 
the major issues affecting international customer service. Statements 
generated were then coded for the next round. The second questionnaire 
consisted of a hundred and fifty six questions summarised from the 
71 More details of the definitions of these variables can be found in Boateng(1997)1 pp. 1-41. 
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previous round. Panelists were asked to rate each statement on a likert 
scale ranging from extremely important to not important. 
As regards current performance vis-a-vis certain customer service 
attributes, panelists were asked to rate the current performance of Pharma- 
chemical sites relative to the competition on a simple likert scale ranging 
from excellent to poor. A brief summary of the results are given in tables 5 
and 681. 
Like stage 3, the panelists were asked to vote again on fifty six percent of 
the statements that received the most votes in stage 4. The average 
response rate for all three rounds was approximately ninety three percent. 
72 More details on the Delphi Findings can be found in Boateng(1997)1 pp. 42-106. 
73 Boateng(1997)1 pp. 55-59. 
74 ibid. pp. 60-63. 
75 ibid. pp. 65. 
76 ibid. pp. 64. 
77 ibid. pp. 67 for some of the attributes. 
78 ibid. pp. 84. 
79 ibid. pp. 91. 
80 ibid. pp. 89. 
81 See page pp. 56 
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Table 5-Response Rate-Customer Service Attributes 
Upon analysis of the responses obtained in stage 4, each panel member was 
sent a summary of how they voted in relation to each statement. In 
addition, the mode, median, mean values were also presented. 
Forty four customer service statements received the most votes82 against 
the extremely important label. By definition, they needed consideration and 
addressing within the next three months. They included the following: - 
0 Quality of product should always be within specification. 
0 There should be collaboration with Freight forwarders: - 
El To improve transit times. 
El To improve information systems. 
0 Freight forwarder must offer flexibility in: - 
Q Emergency shipments. 
Q Special shipments. 
El Rescheduling and rerouting shipments. 
0 Freight forwarder must be able to : 
El Provide a response on the location of a customer order. 
Q Prepare government export declarations. 
Q Adhere to specific shipping instructions. 
82 Mode. 
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21 Offer Certificate of origin on the shippers behalf. 
El Provide rapid response to customer inquires by the customer. 
0 Offer Ocean bill of lading on the shippers behalf. 
0 Freight forwarder must offer consistency in: - 
E( Quality management practices. 
Q Promised pick up dates. 
H Delivery to customers. 
I Overall transit times. 
El Shipment tracing. 
Q Good housekeeping. 
0 Materials mgt. personnel must be consistent in providing quality customer 
service: - 
Q Promised delivery to the customer site should be as per the agreed 
date. 
0 Quantity shipped should always be as per advised. 
0 Customers should be informed of pick up dates from the shipping 
site. 
0 Sites in a channel of distribution must be encouraged to improve: - 
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El Raw material inventory turns. 
Q Finished goods inventory turns. 
0 The organization should develop: - 
El Appropriate polices for managing supply chain as a single entity. 
R1 Strategies for reducing overall supply chain cycle times. 
0 Joint problem solving must be encouraged between supply chain entities. 
O Pharma-chemical sites must: - 
IZI Provide accurate invoice at all times. 
Q Notify the customer of any shipping delays. 
0 Pharmaceutical sites must be: - 
0 Proactive to market sensitive inventory reductions. 
Responsive to unplanned demand and orders. 
0 Be able to forecast and commit to orders. 
0 The following must be aligned: - 
0 Pharma-chemical and Pharmaceutical manufacturing strategies 
0 Marketing and Distribution strategies. 
0 Sites within a product supply chain must work with one set of numbers. 
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0 Supply chain forecast must be managed by an individual. 
0 To improve, sites must admit to errors. 
0 Public recognition must be given to sites that: - 
0 Constantly strive for continuous improvement. 
0 Hold minimum inventories. 
0 Sites must be encouraged to implement activity based costing. 
O Cycle time reduction must part of: - 
0 Each distribution site's objectives. 
Q Each manufacturing site's objectives. 
The majority of the statements that received the highest frequency83 in 
stage 3 against the extremely important label also received the most votes in 
stage 4. Some of the customer service attributes like product quality, 
responsiveness, and flexibility were consistent with earlier findings by 
leading customer service researchers including Lalonde and Zinser(1976), 
Lambert and Stock(1993) Sterling(1985) Levy(1978); Tucker(1983)84. 
Forty statements also received the most votes against the important value 
label. The panelists believed that although these statements impacted 
customer service performance, benefits may not be realized immediately. 
83 The mode 
84 For more details see Boateng(1996)1&2 
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However, it must be addressed within the next 6 to 12 months as it could 
significantly contribute to the continuous improvement initiative. They 
included the following: - 
0 Manufacturing sites must routinely share production schedule data 
0 Pharma-chemical sites must: - 
RI Always use specific freight forwarders and carriers. 
El Offer flexibility in pack sizes. 
t Provide shipping details prior to goods leaving site. 
0 Tracking of dispatched material must be a policy for all sites. 
0A data base of transit times to all destinations must be compiled. 
O Freight forwarder should be willing to configure policy to meet customer 
needs. 
0 The number of freight forwarders must be rationalized. 
0 The organization should actively work with Freight Forwarders to 
improve: - 
21 Overall freight costs. 
El Transport costs. 
Q Handling costs at both ends. 
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El Administrative costs at both ends. 
0 Freight forwarder must be able to offer: - 
El Different modal services. 
C1 Local delivery service. 
0 Door to door service. 
0 Advance cargo space bookings. 
0 Consular documents in local languages to where goods are shipped. 
El Expand or reduce service at no extra cost. 
21 Consistency in fast response to claims. 
OA dock receipt on the shipper behalf. 
Q Electronic packing list to the customers. 
0 Sight and time drafts. 
0 There should be: - 
0 Common systems among manufacturing and receiving sites. 
21 Dedicated support services for users of all information systems. 
0 Less emphasis should placed on profit plan volumes. 
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0 Pharma-chemical sites must be proactive to market sensitive inventory 
reductions. 
0 There should be full EDI between internal supply chains. 
0 Material flows between supply chains need to be simplified. 
0 Inbound JIT deliveries to sites from major supplier must be encouraged. 
0 There should be channel performance metrics. 
0 Sites must be encouraged to implement bar coding systems. 
0 Nominated world class sites must publish their achievements in the 
organization's newsletter. 
0 Entities must routinely benchmark itself against external world class 
operations. 
O Entities should work together to improve product costs. 
0 Group leverage should be used to improve purchase costs. 
A number of customer service attributes including use of specific freight 
forwarders, joint efforts to improve freight costs, common systems among 
manufacturing sites received similar of votes in the previous round. 
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As regards performance, a number of customer service statements were 
considered needing immediate attention by Pharma-chemical sites. They 
included the following: - 
0 The organization should implement electronic invoicing in all internal 
sites within the next 12 months. 
0 There should be a sales order management policy for all Pharma-chemical 
sites. 
O The Pharma-chemical sales order management policy must be reviewed 
every year. 
0 Corporate Logistics must undertake customer satisfaction surveys every 
year" 
0 For continuous improvement purposes, the transit time data base must be 
reviewed twice a year. 
0 Ideally all orders should be: - 
El Shipped on the requested ship date. 
0 Considered a hit if ship on the promised ship date. 
0 Ideally all customer: - 
I Orders should be confirmed within 2 days after receipt. 
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0 Requests should be dealt within 2 days by the supplying site. 
El Late orders should be communicated to the customer 15 days before 
shipment. 
0 CERTIFICATE OFANALYSIS should accompany goods. 
0 For release pending material, CERTIFICATE OFANALYSIS must be 
forwarded a day after order is shipped. 
Not only did the majority of experts express the need for customer surveys 
every year, they also wanted release pending information to be sent to the 
customer within a day. This was consistent with the voting pattern in the 
previous round. 
For benchmarking purposes, the panelists were asked to expressed a view 
ranging from excellent to poor on a number of statements. 
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Table 6 provides a summary of how the panelists voted. 
Round 1 100% Not applicable Not applicable Not applicable Not applicable 
Round 2 90% 1785 1286 1e7 
Round 3 90% 188 1689 1090 191 
Table 6- Response Rate- Benchmarks - 
Performance against a number of these statements were considered to be 
good. They included the following: - 
0 Pharma-Chemical sites routinely inform the customer of the packing list. 
0 Shipped orders routinely conform to product dating standards. 
0 Orders were routinely shipped with 
CJ The correct CERTIFICATE OF ANALYSIS. 
Q Readable CERTIFICATE OF ANALYSIS. 
0 The right packaging. 
Cpl The correct invoice. 
El The correct address and 
85Boateng(1997)1. pp. 77-78. 
86 ibid. pp. 75-76. 
87 ibid. pp. 79. 
88 ibid. pp. 102. 
89 ibid. pp. 95-96. 
90 ibid. pp. 97-98. 
91 ibid. pp. 103. 
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E( Shipped in full. 
0 CERTIFICATE OF ANALYSIS were routinely sent to customer on time. 
O In most cases Pharma-chemical sites were able to respond to unplanned 
demand. 
0 Sites generate a constructive working relationship with each other. 
Although performances against these statements were considered 
satisfactory, the panelists were at pains to stress that when compared to 
world class practices performance92, they left a lot to be desired. Significant 
improvements were thus needed. Based on the parameters set, the voting 
patterns were consistent with previous round. 
The panelists considered the following performance below average. 
They included the following: - 
0 Orders were not routinely: - 
Qx Shipped on time. 
19 Shipped as per the promised ship date. 
0 Supply chain entities did not routinely share production schedule 
information. 
0 Pharma-chemical sites routinely: - 
92 Various company names were solicited from panelists for benchmarking purposes. 
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Z Communicated late orders 5 working days before shipment93. 
Did not acknowledge orders. 
0 Pharma-chemical sites did not offer flexibilit in pack sizes94. 
0 Sites were not knowledgeable about each other needs. 
0 Entities did not share ideas on how to reduce product costs. 
0 Current methods for raising of purchase orders were not in line with world 
class practices. 
0 Entities were not working together to improve overall cycle times. 
0 Current policy for ordering bulk did not serve supply chain needs. 
0 Customers were not routinely informed of pickup dates. 
With these statements, the panelists were of the view that inconsistent 
performance was currently being achieved by Pharma-chemical sites. This 
was thus causing operational problems and as such, urgent attention was 
needed. For example, not only did Pharma-chemical sites not offer 
flexibility in pack sizes, they failed in most cases to ship orders on the 
promised ship date. Panelists also emphasized the need to align the various 
attributes to world class practices through benchmarking. 
93 15 days was the minimum time required to inform the customer of a possible late shipment. 
94 Problem primarily due to Hazardous nature of operations. In less hazardous environments subdividing 
specifically for a customer order is relatively easier. 
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Configuration of an International Customer Services Policy through the Delphi 
Findings 
The main objective of this exercise was to elicit from panel members 
customer service elements that could form the basis for comprehensively 
configuring an International Customer Service Policy for the Pharma- 
chemical entities within the organization. This has been achieved since a 
policy has been developed and successfully implemented. 
The questionnaire was designed in such a way that a measure of current 
Pharma-chemical customer service performances were elicited. Firstly, the 
measure gave a reference point for benchmarking purposes. It also revealed 
how Pharma-chemical entities were performing against the best supplier. 
By requesting Pharmaceutical sites to rate Pharma-chemical sites on 
performance relative to the best supplier, the preferred dimension on 
performance provided a reference point for an improvement program. 
Key Criteria for the Successful Application of the Delphi technique. 
As already mentioned, the Delphi process is a systematic solicitation of 
expert opinion on a subjective and often contentious issue. Its successful 
application is largely dependent on a number of key things: - 
a) Selection of the panel of experts. 
b) Development of Delphi questions. 
c) Commitment of the expert to see the process through. 
d) Phrasing of the questions in the open ended round. 
e) Detailed plan of execution. 
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Selection of Panel experts 
The experts whose views are being solicited constitute the Delphi panel. The 
following must be taken into account when assembling the experts. An 
expert should: - 
1) Feel involved in the problem of concern. 
2) Have some knowledge of the issue under investigation. 
3) Be keen to take part in the study and be willing to see the process 
through. 
4) See the benefits of the exercise and be willing to at least utilize some of 
the findings. 
5) If possible panel members should be nominated by people interested in 
using the results for decision making or analysis. 
Development of Delphi questions 
This stage is equally important as the selection of the Delphi members as, 
should panel members misinterpret the questions, they will provide wrong 
answers or become totally disillusioned with the whole exercise. Ideally 
time must be spent with some of the policy makers to ascertain what 
information is required. To avoid ambiguities and vagueness, the Delphi 
coordinator should ask one of the panelists to thoroughly review the 
questionnaire and its contents before issuing it to the entire Delphi team. 
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Selection of sample size 
The number of experts vary from study to study. However, in most cases up 
to twenty participants on a panel is considered ideal. As can be seen from 
this study, the more people are involved the more questions are generated 
for subsequent rounds. 
Development of first Delphi questions 
In most Delphi studies, the experts are initially asked to respond to broad 
open ended questions. Allowing the experts freedom confer the following 
advantages: - 
a) Adequate time for thinking and reflection. 
b) Avoidance of under focusing on a particular idea. 
c) Avoidance of competition, status, pressures and conformity issues. 
d) No dominance by an individual. 
e) Avoidance of choosing between ideas prematurely. 
f) Anonymity-Panelists are not known to each other. As such they can 
freely express their views. 
With advancements in information technology, the Delphi process can be 
administered via the internet making it relatively faster than postal 
questionnaires. 
In developing and sending the questionnaire via email or internet, caution 
must be taking to ensure that: - 
1) The paper size for printing the questionnaire is set at the appropriate 
standard. 
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2) Both letter and questionnaire contain no technical errors. 
3) Not too much detail should be put into the letter. 
4) The letter must be addressed to each individual panel member. 
5) Pilot run the questionnaire to ensure the instructions for sending it back 
via internet or email works. 
6) Ensure that instructions to return questionnaire electronically contains 
no jargon that is likely to confuse the panel member. 
7) Always put a timing on each round. 
8) If less than 30% has responded within two days of receiving the 
questionnaire follow it up with a telephone or a reminder via email. 
9) Always issue a brief summary to all members and possibly a presentation 
to senior executives within the organization after fifteen working days of 
completing the study and a detailed report soon thereafter. 
10)Time must be spent in selecting the experts as the wrong expert can send 
the wrong response and skew the Delphi results. 
11)Ensure that all experts selected are prepared to see the whole process 
through. 
12)The panel must ideally represent a whole array of people so that all views 
can be captured. Delphi by nature, asks questions that are very 
subjective by nature and caution must be taken in selecting people to be 
on the panel. 
13)Ensure that enough time is allowed to analyze the data for each stage. 
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14)Ensure that each panel member returns the questionnaire as soon as 
possible. 
15)To avoid excessive amount of data analysis and coding restrict the 
number of panelists to twenty. 
16)For the initial round, select panel members whose command of English 
language is good. For an international study, a researcher should ideally 
translate the questionnaire into the local language of each panel member. 
17)Avoid asking too many questions as it could become a statistical 
nightmare!. 
18)Tabulated results should be presented in a very simple way so as not to 
confuse the Policy maker. 
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Chapter 5. 
Process Mappingz. 
Often, process improvements and fast response between processes come 
from finding out and understanding what actually happens in practice. 
Process Mapping is simply a method for describing in detail, the various 
steps involved in carrying out a function, be it a business process or 
otherwise. To Ansler, Busby and William's(1993) process mapping was 
`A simple chain of activities that were executed to achieve a defined goal... 
The goal could be the delivery of a product or a service': 
To Hunt(1996), process mapping was a means 
'To describe the various steps involved in a business process': 
Morrow and Hazell(1992) were of a similar view except that they went 
further to postulate the various steps needed in a mapping exercise. As a 
tool, it helps to give a qualitative picture of activities, their relationships 
and where they occur. Hunt(1996) neatly categorized processes ' under the 
following :- 
Customer process 
Normally received by an external customer. 
95 For more details please refer to Boateng(1997)1 pp. 28-40. 
96 A process is a series of steps designed to produce a tangible or intangible product. 
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Administrative Process 
Process normally carried out within an organization primarily to meet the 
needs of the internal or external customer. 
Management processes 
These are processes taking by management to support the various business 
processes. 
Though primarily used in understanding the activities involved in 
delivering a product97, process mapping has been successfully applied in: - 
1) Time based analysis 98, 
2) Cycle time reduction99, 
3) Product costing, 
4) New product introduction, 
5) Decision support, 
6) Time strategy analysis'°°, 
7) Manufacturing strategy evaluation'°', 
8) Marketing'°2, 
97 Tangible or intangible. 
98 Beesley(1995). 
99 Meyer(1993). 
100 Stalk and Hout(1990). 
101 Tunc(1993) and Ansler and Williams(1993). 
102 Kotler(1995). 
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9) Customer service trackingl03, 
10)Restructuring'°4, 
Today, process mapping has become one of the most talked about business 
tool in productivity improvement circles with its benefits transcending 
organizational boundaries. It was initially developed by General Electric as 
an integral part of its world wide continuous improvement initiative. Its use 
has gradually spread to other industries including Financial, 
Pharmaceutical and Grocery industries. As a tool, it can help an 
organization to: - 
1) Gain a better understanding of a process, 
2) Improve product development cycle times, 
3) Reconfigure a whole process, 
4) Eliminate non value adding activities, 
5) Improve time to market, 
6) Improve product and administrative costs, 
7) Gain faster responses between processes, 
8) Improve material and information flows within and outside the 
organization, 
103 Shapiro (1992). 
104 Barker(1993). 
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9) Gain a better understanding of the internal or external customer and 
10)To outsmart the competition. 
In their landmark publication, Stalk and Hout(1990) postulated that 
organizations that systematically critiqued their processes and looked at 
how much time was spent at each step were able to successfully compete 
using time as a product differentiating strategy. Typical examples include 
Japanese companies which to date, have continuously and successfully 
driven down their overall product development cycle times. 
Inherent in each process step are three variables, i. e. Theoretical, 
Demonstrated and Actual lead-times. A brief explanation of each is given 
below. 
Theoretical cycle time 
The theoretical cycle time is basically the average cycle time achieved from 
process design. The lead-time achieved under a controlled environment 
contains virtually no delay. The theoretical cycle time for each core process 
was gathered in consultation with each process custodian and Technical 
Operations. 
Demonstrated Lead-time 
The demonstrated lead-time is the best average lead time achieved from 
past effected steps. Unlike the theoretical cycle time, the demonstrated 
lead-time contains some delay as there are variables outside the control of 
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the process custodian. For benchmarking purposes, the demonstrated lead- 
times for each core process changes over time and replaced with the best 
average actual lead time. 
Actual lead-time. 
The actual lead-time is the current lead-time being achieved within each 
core process. For benchmarking purposes, the best average of the actual 
lead time becomes the demonstrated lead-time for the next measuring 
period. 
Non-value adding activity(NVA) 
This is basically the delay within the processes. For improvement purposes 
it is compared with the demonstrated and theoretical lead times. 
Velocity 
This is the ratio of 
a) Actual lead time over Theoretical cycle time and 
b) Actual lead time over Demonstrated lead time. 
Mean 
The average of the data set. 
Median 
The middle number in the data set. 
Minimum 
The minimum number in the data set. 
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Maximum 
The maximum number in the data set. 
Standard Deviation 
The distribution of the number around the mean. 
Sum 
The total cycle time achieved for a particular set of process steps. 
Following the data collection exercise it become evident that the actual lead- 
times for each core processes associated with the customer service function 
and two major products were below the demonstrated lead times. 
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Findings 
As already mentioned, improvements come from something as simple as 
working together to find out what you are actually doing. From analyzing 
the various core processes associated with the customer service function, it 
was notable that the current performance was well below the previously 
demonstrated lead times. Failure to continuously benchmark and seek 
ways to improve delivery lead-times between processes had resulted in 
manufacturing logistics uncertainties. 
Core Process 
Order preparation and 
Transmittal 
Actual lead-times Days 
(AFTER)'O' 
2.13 
Demonstrated lead-times 
Days 106 
2 
Actual lead times Days 
(BEFORE)" 
8.5 
Order receipt and entry 1.5 2 5.83 
Order processing 1.5 1.5 3.67 
Warehouse packaging and 
Picking 
1.88 2 4.08 
Invoice preparation ...... 3.25 3 9.33 
Transit time 2 2 6.67 
Total 12.26 12.5 38.08 
Table 7 Process lead times id entifiedt08. 
As can be seen from table 7, the actual lead times were well below the 
demonstrated lead time and failure to initiate the process would not have 
105 After the "virtuous circle of continuous improvement" was initiated. 
106 Best average. 
107 Before the "virtuous circle of continuous improvement" was initiated. 
108 Ibid. See appendix C4. 
70 
highlighted the problem. The customer order cycle which should have taken 
on average twelve days was in practice taking thirty eight days109. 
The process mapping technique was useful in this research in that it 
provided simple but useful protocol around which performance 
improvements were initiated. It appeared to minimize bias and some of the 
problems associated with performance improvement initiatives. In many 
cases, the process custodian provided ideas that were used to refine 
processes. 
Process Mapping Objectives 
The prime objectives of the process mapping exercise were to: - 
1) Understand the processes supporting the customer service function, 
2) Ascertain whether the lead times for each process step was as per the 
demonstrated lead times, 
3) Find ways of improving the present lead times by reducing the delays 
within the processes. 
As can be seen from table 7, the aims have been achieved. 
Key Criteria for the Successful Application of the process mapping technique. 
Experience has shown that there is a tendency for manufacturing 
organizations to quickly join any "process improvement bandwagon" hoping 
for a positive step change in processes and systems. The champions or 
coordinators of such initiatives do so more out of a desire for a quick fix than 
a better understanding of what the real issues and opportunities are. For 
109 pipe refer to Appendix C4, C5 and C6 in Boateng(1997)1 for more details. 
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the successful application of process mapping at other sites the following 
steps must be followed: - 
1. Create management awareness. 
a) Alert management of the benefits to be gained from process 
mapping. 
b) Illustrate with current successful projects within and outside 
the organization. 
2. Agree on a champion from senior management. 
3. Activity mapping. 
a) Identify the core process for each system, be they external or 
internal to the organization 
b) Identify the internal customers for each core process or 
processes. 
c) Identify the external customer for the finished product. 
d) Carry out an activity mapping exercise to identify process steps 
in each core process. 
e) Link all core processes in a linear fashion 
4. The Cross functional team. 
a) Encourage the formation of cross functional teams to oversee 
initiative. 
b) Team should include process custodians. 
c) Appoint a cross functional team coordinator. 
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5. Cross Functional task teams. 
a) Encourage members to form cross functional task teams. 
b) Train task team leaders to facilitate meetings. 
c) Show the team how to apply simple techniques like 
brainstorming and fish bone diagrams to generate ideas. 
d) Introduce the task teams to the process mapping concept 
through an example. 
e) Encourage task teams to appoint a team coordinator. 
6. The task team should focus on: - 
a) Why the process step is needed. 
b) What causes the step to take place as often as it does. 
c) What the linkages between the processes are. 
d) Who and what triggers the process step. 
e) What the process step is dependent on. 
i) What information is needed to successfully carry out the 
process within the demonstrated lead times. 
g) Encouraging the team to gain a greater understanding of the 
problems and opportunities in each core process 
7. Allocation of time 
a) Establish the unit of measurement: - 
i) Days, 
ii) Hours etc. 
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b) Adopt one unit across the various steps in the core processes 
i) Establish: - 
a) The theoretical cycle time for each core process 
b) The "best" Demonstrated Lead time for each core 
process, 
c) Actual lead times with ongoing processes. 
ii) Establish the time frame within which data will be 
statistically analyzed and presented to Management. 
8. Determine the source of information e. g. meetings, management 
systems etc.. 
9. Identification and allocation of lead times. 
a) For each core process, add together the number of hours or 
days in each core process step. 
b) Finally add all the total lead times for each core process. 
10. Flow chart the core process with time as the unit of measure. 
a) Tabulate the collected data for each product in a spreadsheet 
work book. Ideally a worksheet should be designed for each 
product. 
b) Graphically represent the following averages. 
i) The Theoretical cycle time(TCT). 
ii) Demonstrated lead time(DLT). 
iii) Actual lead time(ALT). 
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11. Statistically analyze the mean, median and mode by comparing the 
TCT, DLT, ALT. 
12. Critiquing of Activity steps. 
a) Question each step in the core process. 
b) Aim to continuously eliminate or to improve these process 
steps. 
c) For each core process revise the DLTS with the best average 
from the ALTS- 
d) For each core process use the revised DLT figure as a 
benchmark for the next analysis. 
e) Establish quick hits for the next period. 
General Points to Note 
1. Ensure that team spirit is kept alive by PUBLISHING ACHIEVEMENTS. 
2. Start with EASY QUICK HITS. 
3. ' Never BRUSH ASIDE an idea from the task team. 
4. The Project leader must be seen as been NEUTRAL and IMPARTIAL in 
the whole process. 
5. Project leader must 
a) NOT BE TOO CRITICAL of flaws in processes. 
b) NOT be seen as undertaking a FAULT FINDING exercise. 
c) Must be a GOOD LISTENER. 
d) Encourage people to SEEK WAYS to improve their processes. 
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e) Ensure that initiative is not seen as a FINITE PROJECT or a 
number crunching exercise 
6. Senior management must 
a) GIVE THE TEAM THE SUPPORT needed e. g. training 
b) CREATE an atmosphere conducive and congenial for team 
building and creativity. 
7. Lead time reduction must 
a) BE PART of the site's objectives. 
b) Be seen as a NEVER ENDING CONTINUOUS IMPROVEMENT 
INITIATIVE 
8. Continuously seek best practices from external organizations. 
9. Always compare the DEMONSTRATED, and THEORETICAL times with 
the competition. 
10. Lead times reduction is 
a) About people WORKING TOGETHER towards a COMMON GOAL to 
STAY AHEAD OF THE COMPETITION 
b) About TEAMWORK, GOOD COMMUNICATION etc. 
c) Is a PULL rather than a PUSH driven system of CONTINUOUS 
improvement. 
11. Each entity is a SUPPLIER and a CUSTOMER. 
12. It is not about MANIPULATING numbers. Rather it is about ADDING 
value FASTER than COSTS. 
13. It is not TOP DOWN driven. 
14. It is about ENCOURAGING process custodians to come up with BEST 
alternatives for ACHIEVING a POSITIVE step change in a firm 
competitive position. 
15. It helps to understand WHY things are done. 
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16. With process mapping, always remember the KISS principle: - 
KEEP 
IT 
SIMPLE 
STUPID 
Finally, always MEASURE what is MEASURABLE. 
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SECTION C 
Summary, Analysis & Conclusions and Recommendations. 
Chapter 6. 
Summary 
The purpose of this study was threefold: - 
a) To gain a better understanding of the sourcing strategies of 
Pharmaceutical manufactures. 
b) To elicit a consensus of opinion on what constitutes international 
Pharma-chemical customer service. 
c) Evaluate the current core processes supporting the customer service 
function through process mapping. 
To do this, the following actions were undertaken: - 
1) Reviewed the relevant literature on the Pharma-chemical and 
Pharmaceutical industry. 
w- Undertook a comprehensive survey on the bulk sourcing strategies 
of the major Pharmaceutical manufacturers operating in and 
outside the United Kingdom. 
2) Reviewed the relevant literature on customer service in a distribution 
channel, 
w Successfully carried out a three stage Delphi exercise to 
systematically solicit a consensus of opinion on international 
customer service attributes. 
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3) Reviewed the relevant literature on process mapping. 
w Developed a technique for collecting and improving the various 
core processes vis-ä-vis customer service and two major products. 
w Successfully applied the process mapping technique to evaluate the 
customer order cycle of a number of products. 
Analysis & Conclusions Drawn from the Pharmaceutical Industry 
From reviewing the relevant literature and carrying out the survey on the 
Pharma-chemical/ Pharmaceutical industry, it become obvious that the era 
of stability was over. Generic substitution of branded products and the 
growth in over-the-counter sales will significantly affect market share and 
profit margins enjoyed in the past by the major players in the industry. 
Intrinsically, there is the need to become more customer focused to improve 
both material and information flows in the Pharma- 
chemical/Pharmaceutical pipeline. The industry's biggest customers; 
governments and health care buyers"° will drive the pace of change in the 
industry, resulting in a more dynamic and hostile environment than ever 
before. The changes currently sweeping the industry have forced the 
leading Pharmaceutical manufacturers to adopt new strategies to compete 
and survive into the millennium. 
The strategies adopted include the following: - 
1) Be more customer focused, 
110 The National Health Service (NHS) in the UK and Health Maintenance Organizations(HMO) in the USA. 
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2) Scale back by selling non core activities. 
3) Redefinition of roles in the industry by acquiring Pharmacy Benefit 
Management. 
4) Effective manufacturing logistics and supply chain management policies. 
5) Government actions in terms of encouraging Generic substitution and 
OTC buying of pharmaceutical products indicated that consumers will 
take more responsibility for their health. This in effect means perceived 
values and relative product efficacy will take on a new meaning in the 
industry. For the Pharmaceutical manufacturer to be responsive, 
Pharma-chemical manufacturers will in turn have to re configure their 
customer service activities as the intangibles associated with customer 
service between the two manufacturing entities increasingly become a 
weapon for competitive advantage. 
6) The survey carried out on sourcing patterns of the major Pharmaceutical 
manufacturers indicated size in terms of sales played a major role in 
determining whether a Pharmaceutical manufacturer internally or 
externally sourced its bulk active needs. For example, the survey showed 
that no Pharmaceutical manufacturer with sales of less than £900 million 
had vertically integrated Pharma-chemical plants to satisfy its bulk 
active needs. With over 60% of the top Pharmaceutical organizations 
taking part in the survey, one can confidently conclude that Pharma- 
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chemical manufacturing is still generally an integral part of the 
manufacturing operations of the major Pharmaceutical organizations. 
Analysis & Conclusions drawn from International Customer Service 
From the review of extant literature on customer service, it became clear 
that not only is the setting of a customer service policy an arduous task but 
also measuring the various attributes were difficult if not impossible. Nor is 
this all, for the meaning of the term customer service and the significance 
attached to each of the attributes is still highly situational. As a result of 
the uncertainties within the industry, the role of manufacturing logistics 
and in particular, customer service between Pharma-chemical and 
Pharmaceutical continuum will increasingly become a weapon for 
competitive advantage. It is thus imperative for Pharma-chemical 
manufacturers to re-conceptualize customer service and give it the 
necessary focus it deserves. Increasingly, there is no longer a concern over 
whether a service need will be satisfied but rather, what level of service was 
deemed most appropriate to help an organization sustain its competitive 
advantage. 
Within the current climate, Pharma-chemical manufacturers are beginning 
to seriously re-configure their strategic approaches to manufacturing 
logistics and supply chain management. Instead of just seeking cost 
reduction in manufacturing, customer service could form an integral part of 
the overall competitive strategy. To be successful, the adoption of proper 
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international customer service policies and standards will require a 
substantial paradigm shift in corporate thinking. Initial indications are 
that, partial implementation of customer focused systems can have a 
dramatic impact on a company's profitability and ultimate survival. 
Overall, it has the potential to spearhead the next major revolution in 
competitive practices within the industry. 
One obvious issue that was re-emphasized through the study was the need 
for the customers' view to be represented if any meaningful and practical 
policy and standards were to be set. 
As Lambert and Lewis(1983) and Barabba and Zaltman(1991) pointed out, 
it is imperative that an organization elicit the views of the customer to 
determine their reactions to various service polices in order to evaluate the 
associated costs and benefits. In addition, Bryant and Buffa(1981) 
reaffirmed the need for any customer service policy or standard to be 
measurable, competitive, achievable and more importantly aimed at 
satisfying the needs of the customer. 
In a nutshell, it is extremely important for an organization to have a policy 
that advances its long range profit and return on investment. One should 
however note that the optimum service level is not always the lowest cost 
option but rather the level that provides the firm with the largest long 
range market penetration and profits. 
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Analysis & Conclusions about the Definition and Composition of International 
Customer Service 
1) The methodologies used in this study recognised and took into 
consideration the various issues postulated by leading customer service 
researchers and writers. Previous research in this area was not able to 
conclusively establish the significant international customer service 
attributes. This research integrated the necessary procedures such as 
process mapping for the internal audit to also evaluate the supporting 
systems. It was also constructed so as to be transferable to other sites 
and even industries. Thus the methodology provided managers with a 
definitive and practical techniques for evaluating polices and processes. 
The overall methodologies engaged proved to be very effective in 
achieving the goals of the study as originally developed for evaluating 
and improving customer service performance within the Pharma- 
chemical and Pharmaceutical continuum. 
2) The use of the Delphi technique allowed panel members to generate 
customer services statements and through a process of elimination voted 
on the issues they perceived as needing inclusion in the reconfiguring 
process. The Delphi study on international customer service has provided 
a list of attributes that can be added to the existing list on international 
customer service attributes. The most striking result was the amount of 
statements generated and perceived as being part of customer service. In 
all, a total of one hundred and fifty six statements were generated by 
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Pharmaceutical customers. It proved that customer service as postulated 
by writers including Marr(1980), Lambert and Stock(1993), and 
Wilson(1974) was multi-dimensional in nature and highly situational. 
Nor was this all, for its impact transcended functional, organisational 
and national boundaries. Because of its multi-disciplined nature, it was 
imperative that organisations seek their own solutions to bettering the 
customer service function. Within international supply chains the 
importance of understanding customers and their organisational cultures 
and personalities should always be an important consideration when 
looking at customer service within an entire supply chain. In some cases, 
it might not always be possible to offer similar service packages on a 
global basis. For example a firm with operations in USA, Canada, UK, 
Mali, and Chad, must contend with transport and logistical problems in 
Mali and Chad. These problems can significantly impact customer 
service performance in these countries. 
3) The main objective of the Delphi was to gain an overall understanding of 
what customer service issues were considered within the Pharma- 
chemical manufacturing continuum. Based on this, the sample size" for 
the study was kept to a size which could allow statistically viable 
customer service statements to be elicited from the panelists drawn from 
various backgrounds and countries. At this point, it was not deemed 
III The panel was made up of fifty five professionals and managers from over twenty three countries. In a number 
of cases, there was only one individual representing a country. 
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necessary to demographically segment the customer service statements 
and attributes. Managerially useful segments of international customer 
service were thus not computed. Nor was this all for representatives'12 
on the Delphi panel did not make it possible to identify any statistically 
significant differences between Pharma-chemical and Pharmaceutical 
perceptions on international customer service attributes. 
4) In previous volumes'13 various customer service definitions were given 
by various authors. In most cases, they postulated that customer service 
was supplied by a customer to a supplier. Various authors including 
Lalonde and Cooper et. al extended it to include third party suppliers. 
Most of these authors generally provided valuable insights into customer 
service from a local perspective. From the voting patterns of the 
panelists positioned around the globe, customer service differs from 
country to country and the only way to offer any meaningful service Evas 
to solicit the view of the customer at regular intervals. In addition, the 
best way to improve the supporting systems was to periodically conduct 
activity analysisi14 and look for ideas from outside the company. An 
examination of the voting patterns of the panel members who held 
various positions within their respective companies indicated that 
international customer service could be described as 
112 Over 85% of panelists were drawn from Pharmaceutical manufacturing sites and Corporate Planning. 
113 Boateng(1996)2&3. 
114 For example through Process mapping an organization can systematically critique the sequence of steps 
associated with producing an output be it tangible or intangible. 
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`continuously satisfying a solicited customer need through close working 
relationships with internal and external service providers". 
To fully accomplish this, not only should an organisation solicit the views of 
the customer but also benchmark processes against the best in class. In 
establishing a customer service policy, it is clear that overall market 
penetration and profits should be the main driver. Using this as basis, a 
clearly defined policy could be put together to enable all the relevant parties 
and entities to pursue a common goal. The presence of such a policy will 
help an organisation to become more customer focused. 
Analysis & Conclusions drawn from Process Mapping 
Critiquing of process steps like the customer order cycle can significantly 
raise the level of customer service performance by helping to reduce or 
eliminate the non value adding activities within it. The improvement 
initiative has enabled the site to solve many of its problems. Today, an hour 
each day is site aside to brainstorm and resolve problems. Through this, a 
number of quality problems associated with a number of products have 
largely been eliminated. 
Through the systematic critiquing of the various process steps, the 
organisation has left behind old methods that negatively impacted on 
customer service performance. From analysing the various core processes 
associated with the customer service function, it was notable that the actual 
lead times were well above the previously demonstrated lead times. Failure 
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to continuously benchmark and seek ways to improve delivery lead-times 
between processes had resulted in supply chain uncertainties. As can be 
seen from table 7, the actual lead times were not on par with the 
demonstrated lead times. Failure to measure would not have highlighted 
the delays within the various process steps. 
The Process mapping technique proved to be useful in this research in that, 
it provided a simple but useful means around which performance 
improvements successfully were initiated. It appeared to minimize bias and 
some of the problems associated with other performance improvement 
initiatives. In many cases, the process custodian provided ideas that were 
used to refine processes. 
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Chapter 7 
Research Contribution and Managerial Relevance of the 
Results 
General 
1. The research findings have contributed to both the theory, existing 
knowledge and practice of the following: - 
a) International customer service, 
b) The use of Delphi as a technique for eliciting consensus. 
c) The use of electronic mail in collecting data. 
d) The use of process mapping in activity analysis. 
2. To date, it is the first study to provide a detailed update on the 
sourcing patterns of the major Pharmaceutical manufactures for 
almost two decades. The survey carried out on sourcing patterns of 
the major Pharmaceutical manufacturers indicated the following: - 
a) Size in terms of sales115 played a major role in determining 
whether a Pharmaceutical manufacturer internally or externally 
sourced its bulk active needs. For example, the survey showed 
that no Pharmaceutical manufacturer with. sales of less than £900 
million had vertically integrated Pharma-chemical plants to satisfy 
its bulk active needs. 
b) All manufacturers which took part in the survey used external 
sources for some bulk active needs. 
c) With external sourcing, all manufacturers had some partnership 
style agreement for this purpose. 
115 35% of respondents had sales in excess of £900m. This represented over 60% of the top 50 Pharmaceutical 
organizations in the world. 
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d) Only a handful of Ethical or branded only manufacturers now 
existed and almost all the major manufacturers had diversified 
into Generic, and Over-the-counter manufacturing and sales. 
e) The Pharmaceutical manufacturing industry was heavily 
fragmented and that more consolidation was likely to take place1'. 
3. For international customer service, the need for involvement of people 
from different parts of the world in this study was necessary because 
its impact transcends intra and inter organisational boundaries. To 
date, this study is the first to successfully attempt to elicit in detail, 
the customer service needs of customers located in more than twenty 
countries. 
4. Despite various publications on customer service logistics, it still 
presents problems in some industries. The generic frame work which 
emanated from the study can be embraced to help in the following: - 
a) Reduce pipeline inventories, and 
b) Improve Responses. 
c) Add value faster than costs. 
d) Increase delivery reliability. 
e) Synchronize supply chain schedules., 
f) Control material flows in the various distribution channels. 
g) Improve supply chain costs through lower inventories. 
h) Reduce cycle times through fast response. 
5. For theorists, the study provided a further understanding of: - 
a) International customer service between Pharmaceutical and 
Pharma-chemical manufacturing entities. 
b) What influenced the sourcing strategies of bulk actives by the 
various Pharmaceutical manufacturers. 
116 Green(1995) op cit. See also recent article by Nolf and Wimer(1997) on the industry. 
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c) The use of electronic mail in data collection as opposed to the 
postal method and the telephone. 
d) The constructive application of process mapping 
6. Whilst publications on the Pharma-chemical/Pharmaceutical 
industry, Customer service, Delphi and Process mapping have varied 
in the amount of detail and input requested from practitioners, the 
present study is: - 
a) The first to elicit a consensus of opinion on international 
customer service variables, 
i) Solely from a practitioner point of view and 
ii) In the Pharma-chemical and Pharmaceutical 
distribution channel. 
b) Shed further light on the sourcing patterns of the major 
Pharmaceutical manufactures. 
c) Successfully conduct an internal audit through process 
mapping. 
7. This research is the first to directly look at International customer 
service between a Pharmaceutical and Pharma-chemical 
manufacturer using the Delphi Technique. For the one in the 
industry, this study has offered several concrete contributions as to 
how to conduct a comprehensive but simple international customer 
service audit through the application of both the Delphi Technique 
and electronic mail. 
8. From reviewing the literature on process mapping, this study is the 
first to concurrently compare three variables on each process step. 
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Relevance of the Results to the Organization 
Overall, the relevance of the research to the organization can be grouped 
under three main headings: - 
Sourcing Patterns of Major Pharmaceutical manufacturers 
With over 60% of the top fifty Pharmaceutical organizations participating in 
the survey, the information gleaned on the sourcing strategies of the major 
Pharmaceutical manufactures was deemed statistically significant. To this 
end, it was incorporated into the organization's strategic evaluation on 
make or buy of bulk active products. Being the first major research of its 
kind for almost twenty years, participants who took part in the study gained 
invaluable information for input into their manufacturing strategy 
evaluations. 
Elicitation of International Customer Service Attributes through the Delphi technique 
1) Once the views of the customers were known, a customer service policyl17 
that advanced the site's mission statement was developed. Its 
development was based on the establishment of an objective and 
operational standards that incorporated customer views, competitor 
strengths and weaknesses118. The presence of a written customer service 
policy has made a big difference in the way the site orients itself when it 
comes to dealing with the customer. 
117 See Boateng(1997)1 appendix C7 for a sample of the Customer Services Policy developed. 
118The second part of the Delphi questionnaire enabled the panelists to rate the current performance of Pharma- 
chemical sites relative to the competition and also provide names of perceived world class organizations for 
benchmarking purposes. See also Boateng(1997)1 
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2) With improved information flows, understanding of customer needs 
resulting from the Delphi and process mapping exercises, the site is 
currently much more integrated with their Pharmaceutical customers. 
Such alignment and improvements have resulted in the following: - 
w Reduction in overall lead-time to major Pharmaceutical customers, 
w Improved delivery reliability, 
. "- Reduced inventories, 
w Reduced complexities and, 
'"- More flexible to respond to market changes while simultaneously 
improving operational efficiencies. 
Today, the management of international customer service within the 
industry has taken on a new meaning. Using the demonstrated lead times 
as a benchmark, customer service performance has increased dramatically. 
Process improvement through Mapping 119 
As process lead times have improved, the beneficiary has been the customer. 
Even without the supporting inventories that sustained a number of 
products, the site's customers are getting their orders on time, in full and at 
the right quality. 
No forecast goes exactly according to the plan. With reduced cycle times 
and improved information flows, adjustments are now made to 
accommodate for any changes in front end demand. The information is 
timely fed backwards into the Pharma-chemical manufacturers planning, 
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scheduling, manufacturing, and distribution systems. Such coordinated 
timely flows between entities120 has enabled customer orders to be processed 
and dispatched on time without the need for any safety stock. 
Within a year of initiating process mapping to a number of the site's 
products, and implementing some of the benchmarks defined by the 
customers, the site has currently achieved major improvements in all their 
respective core processes. The most striking thing was how the cross 
functional team were able to work closely with each other to develop a clear 
understanding of each other and ultimate customer needs. Below is a brief 
outline of the achievements to date: - 
1. As can be seen in table 7, significant lead time reductions have been 
achieved in each of the core process lead times associated with 
customer service. Today, the overall average lead time has been 
reduced from 38 to 12 days. 
a) The installation of a fax machine and an in-house electronic 
trading system121 improved the order receipt and entry lead 
time by 74%. 
119 ibid. appendix C4, C5, and C6. 
120 Including various departments. 
121 Internally developed for receiving and transmitting customer orders. 
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2. With the various cross functional teams122 systematically critiquing 
various process steps, average lead times pertaining to 
manufacturing and packaging has being reduced from: - 
a) 28 days to 20 days for an animal health product. 
b) 25 days to 16 days for a human health product. 
3. The site currently :- 
a) Manufacture's an animal health product only to order. 
b) Holds no raw material safety stocks for two major products. 
4. With our major suppliers knowing in advance what we want, major 
raw materials are delivered just in time for use in production. 
5. Site savings well in excess of £1/2 m has already been realized123. 
6. For the first time, the site has achieved same month lead-times for 
manufacture and delivery of a product. This can be attributed to the 
constant and timely information exchange between the site and its 
customers. 
7. Holds virtually no finished goods inventory for two products. 
122 Including process custodians 
123 Ibid. appendix C8-presentations to Senior Management on improvements. 
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8. Exchange production schedules monthly with: - 
a) The supplier of major actives and 
b) Customers. 
9. Customer service performance based on the metrics identified is 98%; 
an increase of 50%. 
10. Incomplete orders resulting from 
a) a partial shipment to date is negligible. 
b) Damaged goods in transit is zero. 
c) No complaints from out of specification product quality. 
11. Customer complaints on variables, e. g. quantity shipped, protocols to 
date is zero. 
12. Standard campaign size has been reduced by 50% for an animal 
health product. 
13. Actual Manufacturing cycle times now average the demonstrated 
manufacturing cycle times for two major products. 
With process reliability and improved customer service performance, the 
focus is now to consistently achieve and improve the customer service 
performance, core process and demonstrated lead-times. The process 
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mapping initiative is currently being extended to the site's other products. 
In particular, within six months of applying this idea to another major 
human health product, the site has achieved the following: - 
1. The site has reduced standard quality operation lead time by 2 days, 
2. On time shipment to a major customer is now 100%. 
3. Manufacturing cycle time is now on par with the average demonstrated 
lead times. 
4. Actual transit lead time to the customer is now at par with the 
demonstrated lead time. 
5. Order turnaround for a humanitarian drug has improved by 50%. 
6. Quality release time for the humanitarian drug has been reduced by 3 
days. 
The improvement to date has in fact exceeded what the site expected. The 
gaining of approval to manufacture another product can be partly attributed 
to the continuous improvement efforts and accomplishments to date. With 
senior management's support, each individual and teams on site are 
continuously questioning their processes and seeking to reduce or eliminate 
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the non value adding activities within it. The culture change will put the 
site in good stead to continuously re-engineer its operations124. 
'24 Every year Fortune Business Magazine undertakes a survey on the top 1000 companies in the US. 
Variables measured include quality of management, quality of services and products, financial 
soundness, innovativeness, environmental, responsibility etc. Fortune every year asks more than 
11000 outside directors and Financial directors to rate an organization in terms of the above 
variables. In 1995 Merck was the second most admired Pharmaceutical organization. [Source 
Fortune, March 4th 1996. pp. F6. ] 
97 
Recommendations 
Aiming for world class performance means adopting and using a number of 
tools and techniques to that effect whilst keeping a close eye on the 
competition. The research has highlighted a number of issues and 
benchmarks that need to be addressed if processes are to be aligned to world 
class practices. To do this, a segmented clock supported by a triangular 
base has been conceptualized to represent the way forward. Each segment 
represents one of the issues identified in the research. To be able to 
successfully implement any of the issues there will be the need to 
continuously conduct internal and external audits to identify and 
implement cost effective best practices that will result in a positive step 
change in market penetration and profits. 
SYNCHRONISED PERFORMANCE 
MANUFACTURING MEASUREMENT 
THE CLOCK OF 
EXCELLENCE 
CONTINUOUS I 
IMPROVEMENT 
ENCHMARKING 
TIMELY 
INFORMATION 
EXCHANGE 
SYSTEMS 
INTEGRATIO 
INTERNAL AUDIT eg. 
PROCESS MAPPING 
EXTERNAL AUDIT eg 
DELPHI TECHNIQUE 
Figure 4-The Clock of Excellence. 
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The development of any customer service policy must be based on customer 
needs, competitors strength and weaknesses. The impact of individual 
customer service activities125 on the level of customer service should be 
quantified to establish any possible deviations from the mean126. Once 
established, regular reports should be sent to the relevant people showing 
performance to date. Actual performance must always be compared to 
clearly defined benchmarks127. If there are deviations, corrective actions 
must be taken128. It is imperative that a well defined ownership and 
accountability is also instituted since the policy alone will not guarantee 
improved performance. Automation and integration of processes can have a 
positive impact on total lead times. Experience has shown that customers 
in most cases prefer delivery reliability to shorter but erratic levels of 
performance primarily because it allows them to significantly reduce their 
safety buffers. With service reliability, a front end customer can spend 
more time in reducing forecasting errors which can lead to savings in a 
number of areas'29. 
The Delphi technique was successfully applied to identify a number of 
customer service and supply chain issues. Supported by continuously 
125 Activities include material logistics and freight forwarder management. 
126 Best demonstrated mean 
127 It should include best practice benchmarks. 
128 Process custodians must be involved in the exercise. 
129 For example raw material and finished product inventories. See also benefits of project to organization 
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seeking to improve processes through process mapping and benchmarking13o 
as shown in figure 4, an organisation can position itself and its products 
competitively. 
The clock of excellence which incorporates process mapping and the Delphi 
technique as supporting tools should not be seen as a panacea for 
eliminating all manufacturing ills. Rather, it should be seen as framework 
for identifying and improving issues associated with processes and 
functions. Customer values change over time. With increasing competition, 
this time frame is getting shorter. To this end, the segments on the clock 
could possibly change with time. The only way to align the clock with the 
latest issues is to go directly to the customer whilst at the same time 
keeping a close eye on both best practices and the competition to identify 
possible world class practices. 
In addition, the following recommendations have been made as a result of 
the study. 
1) Customer service variables identified in this study should be the given 
necessary consideration by all Pharma-chemical sites when evaluating 
their customer service policy. 
2) All the benchmarks identified in the survey must be implemented by 
Pharma-chemical manufacturing sites. 
130 Cavinato(1988) describes benchmarking as "a technique that allows an organization to set operating norms, 
make comparisons against perceived better ways of doing things and to set the basis for all future performance". 
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Continuous Improvement & 
Benchmarking 
Continuous Improvement & 
Benchmarking 
DLT DLT DLT 
Figure 5. Process Mapping concept-TDA Technique. 
3) The process mapping concept must be adopted by other manufacturing 
sites. 
4) The organisation should aim to extend the improvement initiatives to 
external key suppliers. 
5) The Policy maker may use the findings in developing a framework for all 
Pharma-chemical suppliers. 
6) All Pharma-chemical, Pharmaceutical, and Distribution sites should 
institute a policy whereby customer surveys are undertaken every year. 
Such information gleaned from their respective customers can be used to 
improve service performance. 
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7) Corporate Planning should institute a policy whereby customer surveys 
are undertaken every year. Such information gleaned from the customer 
can be used to refine policy issues relating to customer service. 
8) All major suppliers to the organisation should be encouraged to institute 
a policy whereby they conduct customer surveys every year. Such 
information gleaned from the customer can be used to improve service 
performance. 
9) Best practices that exist within the organisation should be published for 
all and sundry to take note. 
10)Senior management must encourage continuous improvement by 
presenting a gift on a yearly basis to sites perceived to be consistent in 
improving and offering world class services. 
11)Process improvements programs should be made available to all 
personnel. 
12)Process mapping and cycle time reduction should form an integral part of 
each manufacturing and distribution sites objectives. 
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Suggestions for Future Research 
The Survey, Delphi, and Process mapping applications have all produced 
meaningful results. Nonetheless, there are still many aspects which will 
require and would benefit from further research. 
Pharma-chemical-Pharmaceutical Industry 
1) The sourcing patterns of the major Pharmaceutical manufactures were 
reaffirmed through this study. A re-investigation of the Pharma- 
chemical Pharmaceutical distribution channels possibly using a different 
research method would either confirm these findings on sourcing patterns 
or shed further light onto this competitive tool. 
2) A comparative study of the manufacturing strategies of the major Generic 
and over-the-counter Pharmaceutical manufacturers and the major 
Ethical and Generic manufactures could also help to understand the 
industry as a whole. 
3) The findings from the survey on the sourcing patterns supported the view 
that the bigger Pharmaceutical manufacturer, the more likely it was for 
it to internally source its bulk active needs. With the current changes 
sweeping the industry, it would be useful to know whether the souring 
patterns of the major players in the industry have altered or should be 
altered in future. 
103 
4) Studies using other groups of people drawn from all sectors of the 
industry should verify the findings of this research, in particular the 
international sourcing patterns of the various manufacturers. 
5) A comparative study between the Pharmaceutical, Electronics and 
Automotive industries could also throw some light on the procurement 
strategies of these companies and the reasons behind them. 
Process Mapping 
1) It would be useful to build a spreadsheet simulation model taking into 
account the demonstrated, theoretical and actual lead-times. 
2) Any process can be mapped. It would be useful to apply the concept to all 
the major functions within the organisation. 
3) It would be useful to encourage all major suppliers to adopt the process 
mapping concept not only to identify the non value adding activities but 
also to eliminate any unwarranted delays and costs. 
4) The concept can also be used to evaluate the current material flow 
patterns within various supply chains and processes. 
International Customer Service 
1) A similar study should be completed which involves participation of more 
junior level managers. It would be interesting to determine if their 
responses vis-ä-vis performance and customer service attributes would be 
the same as the ones chosen by the current panel members. 
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2) Because the statements in stages 2 and 3 were concept statements, they 
were very general in nature. More focused detailed studies should be 
conducted on each statement to determine what elements are significant 
to the field of international customer service. 
3) The methodology engaged for this study was unable to isolate the voting 
patterns in specific regions. To segment the attributes into regions, an 
attempt could be made to expand the sample utilising clustering 
algorithms for such analysis. 
4) Expanding the study to include the other links in Chemical-Pharma- 
chemical-Pharmaceutical-Wholesaling-Dispensing continuums would 
contribute to the generalizability of the findings. 
5) The impact of organisational cultures and personalities could throw 
further light on international customer service performance within global 
supply chains. 
6) Additional studies of the same population could be undertaken to 
determine whether the time of the year influenced the voting patterns. 
7) A number of statements did not get enough votes to be considered for 
subsequent rounds. It will be useful for the whole exercise to be repeated 
with those statements included. 
8) The present research dealt with a channel where both customers and 
suppliers in most cases had a close relationship. The study of other 
channels where there are no such relationships would help shed further 
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light on how customer service is perceived. Findings from this could 
provide more evidence to support the need to conceptualise international 
customer service in the context of an industrial distribution channel. 
Furthermore, it could provide significant strategic information for the 
policy maker in a usable and managerially actionable and acceptable 
form. 
9) One additional study for the foreseeable future would be to 
simultaneously solicit the customer service views of the Pharmaceutical- 
Wholesaler channel of distribution, Pharma-chemical-Pharmaceutical 
channel of distribution and the Chemical-Pharma-chemical channel of 
distribution. This will help to further shed some light on whether 
customer service attributes are similar in each of these channels. 
Finally any research that would shed light on the activities of the major 
Pharmaceutical manufacturers and on international customer service will 
surely be of immense benefit. 
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SECTION D 
Sequence for Perusing the Research and References 
Sequence for Perusing the Research 
The report is divided into five major volumes with each having a number of 
parts. Figure 6 presents a schematic representation of the connections. 
Below is a brief outline as to how the research should be carefully perused: - 
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riyum u. ocyuumu wi purusln9 Ule entire project 
SECTION D-EXECUTIVE SUMMARY 
m- Section D overviews the overall research and the major contribution to 
the following: - 
a) General Research. 
b) To the organization. 
SECTION A-SETTING THE SCENE. 
cr Section A which includes Part 1 overviews the research rationale and 
scope. 
SECTION B-THE PHARMACEUTICAL INDUSTRY 
Section B is made up of five parts. 
a) It starts by overviewing the industry in which the research is 
set in Part 2. Also included in this part are the following: - 
i) The sourcing patterns of the major Pharmaceutical 
manufactures. 
ii) The sponsoring organization. 
b) Part 3 reviews the relevant literature on the customer service 
concept. 
c) Part 4 presents a summary of section B and how Pharma- 
chemical customer service can be re-configured through the 
Delphi technique. 
d) Part 5 and 6 include references and appendices to the section 
B. 
SECTION C-THE MAIN RESEARCH 
w Section C consists of Parts 7 to 11. 
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a) Part 7 details the research methodologies and design, data 
collection methods and statistical analysis. Part 7 also includes 
a time based process map of the current path of a customer 
order within a supply chain. 
b) Part 8 presents the formal findings of the research. 
c) Part 9 summarizes the research and present the conclusions, 
recommendations and areas for further study. 
d) Parts 10, and 11 include the references Bibliography and 
appendix C. 
SECTION E-PERSONAL PROFILE 
m- Finally section E which includes Part 13 provides a personal profile, 
competencies gained, and ongoing activities within the organization. 
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